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Hypoxic pulmonary vasoconstriction (HPV) is a unique physiological response of the lung that 
acts to optimize gas exchange by diverting blood flow from poorly ventilated regions.  The 
endothelium has been thought to play a mostly modulatory role in this phenomenon through the 
synthesis of vasoactive agents such as nitric oxide (NO), prostacyclin, and endothelin.  Data is 
provided showing that acute hypoxia induces increases in NO biosynthesis, promoting S-
nitrosation of the metal binding protein metallothionein (MT), which resulted in intracellular 
release of zinc.  Hypoxia released zinc induced contraction of pulmonary endothelial cells and 
contributed to vasoconstriction of small, non-muscularized intra-acinar arteries in isolated 
perfused mouse lungs (IPL).  The relevance of this NO/MT/Zn pathway in HPV was illustrated 
by pharmacological inhibition of NO synthesis and analysis of the response in MT knockout 
(MT-/-) mice, both of which resulted in a blunted pressure response to hypoxia in IPL.  Signaling 
pathways were delineated, indicating how changes in intracellular zinc can alter the actin 
cytoskeleton and promote cellular contraction.  It was found that either hypoxia or exogenous 
zinc resulted in increases in the formation and alignment of actin stress fibers. These changes 
were mediated through the inhibition of myosin light chain phosphatase (MLCP), which 
promoted phosphorylation of myosin light chain (MLC) and tension generation.  Activation of 
PKC appeared to play a role in this process, as indicated by activation and translocation of the 
enzyme in response to both hypoxia and/or increases in labile zinc, and by the blunted 
contractile response in isolated endothelial cells following pharmacological inhibition of PKC or 
utilization of a PCKε dominant negative construct. These data suggest that the NO released in 
response to hypoxia promotes increases in MLC phosphorylation through zinc-dependent 
pathways, which in turn are responsible for the force induction and cell stability necessary to 
elicit an active contractile response in pulmonary endothelium. 
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PREFACE 
 
I believe Neil deGrasse Tyson was right when he said “We are all connected: to each 
other, biologically; to the earth, chemically; to the rest of the universe, atomically,” for 
science has taught me that everything we learn is a joint effort.  The people that give 
you a reason to keep going every day, the environment that nurtures your thoughts, and 
that greater context that makes us believe we are part of something much bigger.  I feel 
immense gratitude to all the people and events that have made this possible: my family 
and childhood friends, who have always loved my geeky and loving ways; those who 
guided my questions so that I could move on to better ones; and, finally, those who 
have filled my heart with love so that I can fuel my life with a big smile every day.   
 First I should thank Drs. Claudette St. Croix and Simon Watkins for their constant 
support and belief that this chemical engineer from Colombia did in fact have a sense 
for biological phenomena.  Thank you for teaching me how to “see” and communicate 
what the tiny cells are trying to say.  I am also thankful to my committee members for 
their insight and perspective, which really contributed to this project and my personal 
growth.  Thank you CBI, for it was a great place to grow as a researcher; everyone had 
something interesting to contribute to this project; and especially Katy Baty, who was 
with me side by side in those initial years and taught me to work hard but play even 
harder.  Great thanks to the University of Pittsburgh as a community, with people who 
truly went out of their way to make me believe I belonged there; and for allowing me to 
meet my very best friends, who in time turned into a real, whole-hearted family.  
 Finally, I would like to thank my family.  My parents and brother made me believe 
I could do anything I set my heart to, and my extended family made me always feel at 
home no matter where I was.  But most of all, I would like to thank my new family, the 
one I found and built in Pittsburgh. Frank and Auki, you made this possible, you are my 
inspiration and this will be the beginning of great things to come.  
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1 INTRODUCTION 
 
 
 
1.1  HYPOXIC PULMONARY VASOCONSTRICTION 
 
Hypoxic pulmonary vasoconstriction (HPV) is responsible for the diversion of blood flow 
away from the fetal lungs in the uterus.  After birth, the alveoli expand and as the levels 
of oxygen rise, vessels dilate promoting oxygenation1-2.  In adults, HPV promotes 
ventilation-perfusion matching by diverting blood flow away from poorly ventilated 
regions of the lung through local vasoconstriction.  This contractile response to hypoxia 
is opposite of what happens in the systemic circulation, where resistance vessels dilate 
when the partial pressure of oxygen (PaO2) decreases in order to maintain the tissue’s 
metabolic demands3-5. 
 
1.1.1 Historical perspective 
 
The initial observations of the phenomenon of hypoxic vasoconstriction were described 
in the 1890s by Bradford and Dean with reports of asphyxia resulting in a rise in 
pulmonary arterial pressure6.  Later in the 1940s, reports began to emerge detailing the 
presence of enlarged hearts in men living in the Andes in comparison with men living at 
sea level7.  But it was not until the observations by von Euler and Liljestrand8 published 
in 1946 that the phenomenon received more attention and that the links between the 
previous studies began to be understood.   
Von Euler and Liljestrand’s experiments took place in anesthetized 
spontaneously breathing cats8 .  These experiments showed an increase in pulmonary 
arterial pressure (PAP) when the animals were breathing a hypoxic mixture (10-11% 
O2), which was quickly normalized when the animals were given atmospheric air to 
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breathe.  The authors hypothesized that the contraction of pulmonary vessels may be 
redirecting the flow away from poorly ventilated sections, contributing to more efficient 
oxygenation.   
A year later in Cournand’s lab, similar studies were performed in awake healthy 
humans using pulmonary artery catheters.  These studies again showed an increase in 
pulmonary arterial pressure and pulmonary vascular resistance with only a slight 
increase in systemic peripheral resistance9.  Currently, HPV is known to be a highly 
conserved mechanism present in mammals, reptiles and even fish10-11.  On the other 
hand, a recent report has shown that the systemic response to hypoxia in vertebrates is 
much more variable than originally thought12.   This study, which included one species 
from each class of vertebrates, compared the responses of different systemic isolated 
vessels and proposed that systemic hypoxic vasodilatation is mostly limited to the 
microvasculature, and that its occurrence in the macrovasculature is more the exception 
than the rule12.   
 
1.1.2 Physiologic significance  
 
In humans where the normal alveolar PO2 is 100 mmHg, a decrease below ~60mmHg 
quickly initiates pulmonary vasoconstriction13.  On the other hand, hypoxemia of as low 
as 10mmHg in mixed venous blood (without alveolar hypoxia) does not result in a 
distinct contractile response, showing that HPV responds to local alveolar ventilation 
specifically14.  
HPV is of great advantage to the fetus and optimizes oxygenation under 
conditions where there are regional differences in partial oxygen pressure, such as local 
airway obstruction and atelectasis in adults. It is thought that local vasoconstriction can 
efficiently maintain oxygenation by diverting the flow to better ventilated areas, and the 
contractile response can be sustained for hours15.  In the case of diffuse hypoxia, the 
initial contraction has been found to decrease over time and is associated with a 
pathological outcome16.   
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1.1.2.1 Pathological conditions 
Both spatial and temporal conditions are important factors associated with the effect of 
HPV.  While the changes promoted by acute hypoxia (exposure in the range of minutes 
to hours) are readily reversible with exposure to normal oxygen pressure, that is not the 
case with chronic hypoxia (associated with exposure on a range of weeks)17.  A 
prolonged exposure to alveolar oxygen partial pressure (PAO2) of less than 75mmHg is 
of clinical importance.  The presence of these oxygen levels in a persistent or 
intermittent manner may cause pulmonary hypertension.  Persistent chronic hypoxia is 
found in conditions such as chronic bronchitis and emphysema, while intermittent 
exposure is associated with early stages of chronic obstructive pulmonary disease 
(COPD) and obstructive sleep apnea.  In response to both, chronic and intermittent 
hypoxic exposure, there is epidemiological evidence linking them to hypertension 
development due to vascular remodeling and right heart hypertrophy18-19 .   
Prolonged exposure to hypoxic environments due to high altitude may also lead 
to adverse results. While the oxygen pressure of inspired air (PiO2) a sea level is 
150mmHg, at 3000m elevation PiO2 decreases to 100mmHg, and at about 5000m 
elevation it decreases to 75mmHg.  Exposure to high altitude may lead to acute 
mountain sickness or high altitude pulmonary edema (HAPE).  While acute mountain 
sickness usually resolves over time or with rapid descents back to low altitude, HAPE is 
a much more serious condition, since the high pulmonary arterial pressure unevenly 
affects capillaries, resulting in endothelial disruption and high permeability pulmonary 
edema20.  Fortunately in many cases of HAPE, a rapid descent to low altitude is 
beneficial and shows that endothelial leakage is reversible. HAPE does not develop in 
everyone, as this condition depends on the degree of susceptibility of the individual, rate 
of ascent and final altitude reached21.  Depending on the rate of ascent, between 0.2 
and 6% of individuals develop HAPE at 3500m and 2 to 15% at 5500m22-23. It is 
interesting to note that people living at high altitudes have shown a blunted hypoxic 
response as an adaptation to chronic hypoxia24 
Several changes occur in response to an ascent to high altitudes or during 
chronic obstructive pulmonary disease (COPD)25.  The most marked change in 
response to alveolar hypoxia is the muscularization or appearance of smooth muscle 
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like cells (defined by expression of α-smooth muscle actin) in small (<70µm) pulmonary 
arterioles, which usually do not have a continuous smooth muscle layer.  Smooth 
muscle and endothelial cells show phenotypic changes, which result in increases in cell 
proliferation and decreases in apoptosis26. Endothelial cells have been shown to 
increase expression and bioactivation of TGF-β in response to hypoxia which in turn 
activates smooth muscle cell proliferation and increases production of extracellular 
matrix27.   Vascular remodeling is then the result of medial and adventitial thickening as 
well as cellular transdifferentiaion28.    
Currently, it is thought that the vascular remodeling observed in chronic hypoxia 
derives from persistent Rho Kinase (ROCK) activation, and researchers are beginning 
to investigate the therapeutic potential of inhibiting this signaling pathway, with 
promising results29-30.  A more detailed explanation of Rho and ROCK signaling will be 
described the endothelial contraction section of this introduction.  In addition, Src family 
kinase and changes in reactive oxygen species (ROS) have been proposed to be 
among the initiating factors leading to vessel thickening and hypertension31-32. 
Impairment of HPV can also result in adverse effects as is the case in 
hepatopulmonary syndrome or isovolemic hemodilution (used in order to decrease 
blood transfusion during anesthesia).  In both cases, there is a decrease in hematocrit, 
which has been shown to inhibit HPV33-34. Evidence has shown that nitric oxide (NO) 
scavenging by a normal number of red blood cells is important in maintaining vascular 
reactivity and that the mis-matching of ventilation/perfusion may result in severe 
hypoxemia33,35-36.   
 
1.1.3 Models of HPV  
 
In von Euler’s and Liljestrand initial study, it was noted that the increase in PAP was not 
influenced by vagotomy8, indicating an intrinsic self-regulated mechanism in response 
to alveolar gases. Further experimentation in isolated lungs and vessels, pulmonary 
arterioles allografts and isolated smooth muscle cells, demonstrated that HPV is not, in 
fact, mediated by the autonomic nervous system37,38. This finding prompted the wide 
use of simplified models in order to dissect specific processes.  Unfortunately, it also 
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uncovered discrepancies and variability in the responses between experimental 
preparations. 
One important difference between models is the profile of pulmonary arterial 
pressure (PAP) increase in response to hypoxia.  The most frequently found response 
in vivo is a monophasic increase in PAP; in contrast, isolated pulmonary arteries (and 
some perfused lung models), show a biphasic pressure increase.  The biphasic 
response has been proposed to be the product of two overlapping processes.  The 
initial phase, a rapid and transient contraction lasting approximately 10–15 mins, and a 
second phase which slowly increases to a sustained contraction level above normal at 
approximately 30–40 minutes39.  A more detailed description of these profiles and their 
association with increased intracellular calcium will be addressed later.   
Interspecies differences in hypoxic response are very marked, with cattle being 
highly sensitive to hypoxia and rabbits showing the least responsiveness40. Rats and 
mice, which have a much smaller response than dogs and cats, are frequently used 
models because of their easy maintenance and availability of transgenic strains.  Of 
these two species, mice show a milder hypoxic response. Many reports also show 
differences in the contractile response between strains of mice41 and a range of 
susceptibility among humans42.  Humans have a weaker response than rats and in 
addition show different levels of increase in mean PAP in response to hypoxia ranging 
from 2–15mmHg43.    
 
1.1.4 Site of HPV 
 
In 1966 it was shown that pulmonary vasoconstriction is inversely related to the 
diameter of the vessel44.  It was later determined that vasoconstriction occurs upstream 
of arterioles 30–50μm in diameter and predominately in 200–300μm diameter arterioles 
(with small variations reported among species)45-47.    
Vessel wall thickness and composition changes with vessel radius48.  As 
previously mentioned, the reactivity of the vessels in the lung occurs in response to low 
oxygen levels in the alveolar space and not the blood14.  Since oxygen must travel from 
the alveolus through epithelium, interstitial tissue, smooth muscle and endothelium in 
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order to finally reach the blood, it is important to note that the cells are not exposed to a 
gradient of oxygen levels, but instead remain in equilibrium with the gas concentration in 
the alveolar space.  This implies that every cell between the alveolar space and the 
blood is exposed to the same oxygen partial pressure and may initiate a response to 
hypoxia48.  Findings that endothelium-denuded pulmonary vessels and isolated smooth 
muscle cells contract in response to hypoxia indicated that smooth muscle may be both 
sensor and effector of hypoxic-vasoconstriction48-50.   
 
1.1.5 Oxygen sensing during HPV 
 
Various mechanisms have been proposed for the quick onset of hypoxic-induced 
vasoconstriction including: mitochondrial or enzymatic changes in reactive oxygen 
species and alterations in mitochondrial calcium management51.   Various tissues in the 
human body are known as specialized oxygen sensors: carotid body, pulmonary 
vessels, neuroepithelial bodies and fetal adrenomedullary chromaffin (AMC) cells.  
Physiologically, they are exposed to different ranges of oxygen and the consensus is 
that the mitochondria are the key sensors in most of these systems, even though the 
translated response may be very different.   
 The mitochondrion is the largest oxygen consumer in cells, and consequently 
highly sensitive to changes in PO2. Modification of mitochondrial function has been 
reported to alter oxygen sensing in lung vessels, as well as other oxygen sensor 
systems like the carotid body and AMC51.  Alterations in mitochondrial function may 
signal through changes in redox or energy state51.   
Recent studies have also proposed that mitochondrial signaling pathways may 
confer specificity to the hypoxic response to pulmonary smooth muscle versus 
mesenteric smooth muscle:  the mitochondria and endoplasmic reticulum are much 
closer to the cell membrane in the lung, thereby increasing the sensitivity to these 
signaling pathways52.  Still, much controversy surround the sensing of decreased 
oxygen tension in the lung, with three hypotheses getting the most attention: the redox 
hypothesis, the reactive oxygen species (ROS) hypothesis and AMP/ATP ratio 
hypothesis (summarized in Figure 1).   
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Figure 1.  Different oxygen sensing hypothesis converging in increased cytosolic 
calcium. A. Redox theory. Oxygen limitations result in a decrease in reactive oxygen 
species (ROS), which reduces the cytosolic environment, inhibiting potassium channels, 
resulting in depolarization and calcium entry through L-type calcium channels.  B. ROS Theory. 
Decreases in oxygen inhibit cytochrome c or activate NAD(P)H oxidase (NOX) resulting in an 
increase in ROS and calcium release from intracellular stores. C. AMP/ATP Theory. Hypoxia 
results in altered mitochondrial function, with an increase in the AMP/ATP ration, resulting in 
mobilization of calcium from intracellular stores. 
 
1.1.5.1 The redox hypothesis.   
The redox hypothesis, developed by Weir and Archer, proposes that decreased 
generation of reactive oxygen species (ROS) in the mitochondria results in a reduced 
environment within the cytosol in smooth muscle cells53-55.  Approximately 2% of 
electrons in the electron transport chain are lost by donation to O2 to form superoxide 
(O2
-)56. The decrease in ROS has been shown to result from alterations in complex I or 
III due to O2 limitation. The decrease in mitochondrial ROS generation in turn reduces 
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the cytosolic environment of the cell (which may be measured by the ratio of oxidized 
redox couples like GSH/GSSG and NADPH/NADP).  These environmental changes 
promote Kv channel inhibition, depolarization and voltage dependent calcium entry 
though L-type Ca2+ channels54,57 (Figure 1A).  However, L-type channel blockers have 
been shown to only partially inhibit the initial phase of hypoxia-induced contraction of 
isolated pulmonary arteries, and antioxidants are not capable of mimicking hypoxic 
induced contraction as would be predicted, resulting in controversy around this sensing 
theory58-59.   
 
1.1.5.2 The ROS hypothesis.   
ROS may arise in the mitochondria as a result of the electron transport chain, during 
oxidative phosphorylation.  The oxygen which is normally reduced to water, is 
prematurely reduced to superoxide radical ·O2
-.  In this case, it has been proposed that 
the decrease in oxygen availability inhibits cytochrome c in complex IV of the 
mitochondria, altering the cellular energy status and consequently increasing ROS 
generation60.  After conversion by superoxide dismutase (SOD), the resulting H2O2 
freely diffuses to the cytosol and promotes calcium mobilization from IP3 and ryanodine-
gated calcium stores61  (Figure 1B).  Supporting this hypothesis are studies showing 
that hypoxia induces increases in ROS in isolated rat pulmonary artery smooth muscle 
cells (RPASMC) using fluorescence resonance energy transfer (FRET)-based probes62-
63. Also, it has been shown that hydrogen peroxide induces sustained contraction of 
isolated pulmonary arteries and calcium release in smooth muscle cells61,64-65. Finally, 
ROS have also been reported to mediate rho kinase (ROCK) activation, which is a key 
element in the development of pulmonary hypertension in response to chronic 
hypoxia31. 
Another source of ROS is NADPH oxidase (NOX), a membrane bound 
superoxide producing complex.  Most evidence associated with NOX response to 
hypoxia points to ROS production.  A recent study reports a ROS-induced ROS 
production pathway, where mitochondrial ROS activates NOX through PKCε, enhancing 
ROS production and elevation of intracellular calcium contributing to contraction in 
isolated pulmonary arteries64.  Finally, a recent report proposed that ROS increase in 
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the intermembrane space in the mitochondria, and diffuse to the cytosol of smooth 
muscle cells; whereas there is actually a decrease in ROS in the mitochondrial matrix66. 
 
1.1.5.3  AMP/ATP ratio hypothesis.   
This hypothesis is based in the fact that hypoxia doubles the AMP/ATP ratio in 
pulmonary arteries, which is usually maintained at a constant level67.  It is thought that 
hypoxia inhibits mitochondrial function, increases AMP/ATP ratio, activating the highly 
sensitive AMP-activated protein kinase (AMPK) pathway and cyclic ADP-ribose 
(cADPR)-dependent Ca2+ mobilization from ryanodine-sensitive sarcoplasmic reticulum 
stores (Figure 1C). Consistent with this hypothesis is that AMPK is highly expressed 
(four-fold) in pulmonary arteries in comparison to mesenteric arteries and its inhibition 
has been reported to reverse HPV67. 
 
1.1.5.4  Additional pathways.   
In addition to the previous pathways, mitochondria could be directly contributing to 
increases in cytosolic calcium in response to hypoxic exposure68. There is a calcium 
uniporter in mitochondria driven by the organelle’s membrane potential and cytosolic 
calcium concentration69-70.  Impaired respiration may result in a decrease in membrane 
potential and promote calcium release to the cytosol as is the case in the carotid body 
cells71.  The role for this pathway in HPV is currently under investigation.  
  
1.1.6 HPV signal transduction 
 
It is now widely accepted that smooth muscle plays a key role during HPV and that 
oxygen sensing pathways converge in the increase in cytosolic calcium72.  The increase 
in calcium originates primarily from the extracellular fluid but also from intracellular 
stores, and promotes the activation of contraction pathways. According to the redox 
hypothesis, which states that hypoxia results in a decrease in ROS and a more reduced 
cytosolic environment, a key element promoting calcium mobilization is the inhibition of 
potassium channels. Various voltage sensitive potassium (Kv) channels, but specifically 
Kv1.5
62 as well as two-pore acid-sensitive potassium channels (TASK-1) have been 
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shown to be sensitive to acute oxygen changes, resulting in membrane depolarization73.   
In addition, a signaling pathway has recently emerged indicating that hypoxia may 
promote production of ceramide by neural sphingomyelinase, which in turn activates 
PKCε and results in Kv inhibition in pulmonary arteries74. 
The biphasic contractile response observed in small intrapulmonary arteries has 
been associated with a biphasic elevation of calcium in smooth muscle75. The initial 
transient calcium release has been proposed to derive from intracellular stores, while 
there is a concurrent influx of calcium from the extracellular space through voltage 
dependent and independent mechanisms57.  Voltage dependent L-type calcium 
channels as well as nonspecific cation channels have been shown to promote calcium 
influx from the extracellular space during hypoxic conditions76-77. Inhibition of L-type 
calcium channels induces only a partial inhibition of HPV, indicating that calcium 
increases may also derive from additional signaling pathways.  In addition, recent 
studies have implicated the activation of voltage-independent store operated Ca2+ entry 
(SOCE) channels during the initial contractile phase, as well as the translocation and 
activation of transient receptor potential channels (TRPC), but still further investigation 
is needed to determine the relative importance of each channel type 78 79.  
It is currently accepted that hypoxia-derived signaling pathways converge in an 
increase in intracellular calcium in pulmonary smooth muscle cells resulting in cellular 
contraction80.  In general, cellular contraction is mediated by the sliding motion of motor 
protein myosin toward the plus or barbed end of actin filaments, decreasing the space 
between consecutive filaments and generating tension.  Structurally, myosin has two 
heavy chains and two pairs of light chains.  The heavy chains consist of a globular head 
and a tail.  Initially the globular head interacts with actin, ATP binding results in actin 
release and conformational change, resulting in a lever arm movement or stroke.  ATP 
hydrolysis results in production of ADP and Pi, which are released upon rebinding to 
actin.  
Regulation of myosin movement is obtained by phosphorylation of the regulatory 
myosin light chain (MLC), which promotes the extended “active” conformation, 
enhancing velocity and force of the cross-bridging circle, while dephosphorylation 
stabilizes the inhibited bent conformation81. The phosphorylation state is determined by 
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the balance between MLC kinase (MLCK) and MLC phosphatase (MLCP); where an 
increase in MLCK activity, as well as a decrease in MLCP activity, may promote 
contraction.  MLCK is a serine/threonine-specific protein kinase activated by changes in 
intracellular calcium, and may be inhibited by phosphorylation82.  MLCP is a 
holoenzyme with a catalytic subunit (PP1), a targeting subunit (MYPT1) and a small 
20kD subunit of unknown function, also inhibited by phosphorylation. The cytosolic 
increase in calcium concentration derived from low oxygen levels contributes to smooth 
muscle contraction through calcium-calmodulin activation of myosin light chain kinase 
(MLCK)81.   
   
1.1.6.1 Cellular contraction.   
In order for a vessel lumen diameter to decrease, the surrounding cells, including 
endothelium and smooth muscle, must change shape through contractile pathways.  
The hypoxia-derived increase in intracellular calcium in pulmonary smooth muscle cells 
promotes cellular contraction80.  In general, cellular contraction is mediated by tension 
generation along stress fibers.  Stress fibers are formed by bundles of 10–30 actin 
filaments83. Actin is a small 5nm protein, but formation of filaments and fibers allow it to 
alter the cell’s shape, mediate motility and manage intracellular transport84.   
 Actin filaments are periodically bundled by α-actinin, alternating with non-muscle 
myosin to create a dynamic backbone orchestrated by actin-myosin interactions.  The 
intercalated presence of bundling protein α-actinin was initially thought to impair 
contraction.  More recent findings have shown that due to α-actinin binding dynamics, 
the displacement by contraction can be quickly followed by rebinding and maintenance 
of integrity of the fiber.85  
 Actin filaments possess an inherent polarity due to a cleft found in the monomer 
which promotes unidirectional polymerization, with monomers being added exclusively 
in the designated plus (+) end. This contributes to a coordinated contraction since 
myosin moves towards the + end of filaments, sliding the filaments closer together and 
shortening the bundle. In general, the polarity of stress fibers is mostly uniform at the 
cell’s periphery and mixed in the center, giving the cell specific contractile properties86. 
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Cells have been proposed to contain at least three different types of stress 
fibers: ventral stress fibers, transverse arcs, and dorsal stress fibers
85
.  Ventral 
stress fibers are contractile filament bundles attached to focal adhesions on both 
ends of the ventral cell surface. Transverse arcs are curved bundles unattached to 
the cell membrane parallel to protrusive lamella and that move towards the center of 
the cell.  Dorsal stress fibers are unilaterally attached to focal adhesions while 
resting on transverse arcs at the opposite end.  Since transverse and dorsal stress 
fibers do not have attachments at both ends, it is doubtful that they have a role in 
contraction since tension generated within cannot be transmitted.  There is evidence 
that both fiber types may contribute to the cell’s rigidity and load distribution and that 
they may be converted to ventral stress fibers over time
83
.  In addition, dorsal stress 
fibers with uniform polarity might have a role in myosin-based vesicle and protein 
trafficking towards the cell’s surface87. 
As previously mentioned, ventral stress fibers have contractile properties.  
Contraction in ventral fibers appears to be mediated by sliding of overlapping filaments 
with opposing directions, resulting in shortening in the central region of the cells, which 
may be transmitted along the fibers.   Since ventral stress fibers may span the whole 
cell, the tension generated can be transmitted through focal adhesions to opposing 
sides of the cells88.  Force transmission through focal adhesion from tension generated 
along ventral fibers is supported by findings that forces applied to the substratum are 
aligned with the direction of ventral fibers89. 
 
1.1.6.2  Signaling pathways regulating contractility.   
Most of the work in stress fiber signaling pathways has focused on calcium changes 
and Rho downstream signaling, which appear to be the most important regulators under 
physiological conditions90.  Calcium can directly bind to calmodulin (CaM), which 
activates MLCK, leading to myosin regulatory light chain phosphorylation and increased 
contraction.  Rho is a member of the Rho family of GTPAses, cycling from an active 
GTP-bound state to an inactive GDP-bound state, while ROCK-1 and ROCK-2 are 
serine/threonine kinases. Rho is involved in the regulation of several cellular processes 
including stress fiber and focal adhesion formation, alteration of cell morphology, 
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aggregation, cytokenesis, ruffling, neurite retraction and smooth muscle contraction91. 
The observation that Clostridium botulinum C3 toxin results in fiber disassembly led to 
the idea of Rho family members regulating actin stress fiber formation92. Later it was 
confirmed that Rho and downstream Rho kinase (ROCK) promote stress fiber 
formation93. 
Rho and ROCK have been shown to interact with at least four contraction 
promoting pathways during hypoxic pulmonary vasoconstriction. This interaction can be 
through direct phosphorylation of MLC, which increases the ATPase activity,94 or by 
MLCP inhibition through three distinct interactions: 1) phosphorylation of MLCP 
targeting subunit MYPT195; 2) activation of CPI-17 which in turn inhibits MYPT1 (which 
may also result from PKC activation)96; and 3) activation of zipper-interacting protein 
kinase (ZIPK)97-98.  Supporting the evidence of ROCK having an important role in HPV 
is the fact that the ROCK-inhibitor Y-27632 has been shown to abolish the sustained 
phase of HPV in in-vivo, ex-vivo and in-vitro models99. 
 
1.1.6.3 Force transmission.   
Anchoring of stress fibers at focal adhesions is necessary for force transmission to the 
extracellular matrix.  Focal adhesions are multi protein arrangements containing 
structural and signaling molecules that are tethered to the extracellular matrix through 
integrins.  Some of the proteins that make up focal adhesions are vinculin, talin, α-
actinin, focal adhesion kinase (FAK) and paxillin and most of them enable and modulate 
interactions with the actin cytoskeleton.  Focal adhesions are highly dynamic structures 
and work as mechano-transducers, regulating gene expression and even cell fate100-101. 
 Stress fibers have a basal constant tension which is equilibrated by adhesion 
strength102.  It is known that stretching of actin bundles associated with focal adhesions 
induces an increase in size and stability103.  In the same manner, stress fibers may not 
only transmit force generated within the cell but can also act as sensors104.  Supporting 
this idea is the fact that stress fibers have direction-dependent dynamics, which result in 
anisotropic mechanical properties at the cellular lever and allow cells to have a 
directional response to strain derived from physiological forces105.   In the vasculature, 
this translates to the actin network actively responding to both chemical and mechanical 
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signals in a synchronized manner, altering cell shape, and in turn vessel diameter in 
order to regulate perfusion.   
 
1.1.7 Role of endothelium in HPV.   
The pressure and calcium release profiles in response to a hypoxic stimulus in denuded 
vs. intact pulmonary vessels are different39.   As previously mentioned, intact isolated 
pulmonary artery models show a biphasic pressure response to hypoxia, consisting of 
an initial transient constriction peaking at around 5–10 mins, followed by a slow 
developing sustained component peaking at approximately 30–40 mins106.  The second 
slowly developing pressure component has been demonstrated to start concurrently 
with the transient phase and to be endothelium dependent, in that it is not present in 
denuded vessel models75.  Most in vivo and isolated perfused rat lung models show a 
monophasic sustained pressure response placing importance on endothelial-mediated 
components of the response107.   
Intracellular calcium concentration does not match perfectly with the degree of 
MLC phosphorylation or vessel contraction in the intact isolated pulmonary artery 
model, indicating that another mechanism may be involved in contraction regulation.  
Calcium shows a transient increase followed by a plateau at above resting 
concentration, while tension continues to rise during the second phase.  This suggests 
that endothelial cells may increase the calcium sensitivity during the sustained phase58.  
Increased sensitivity to calcium has been associated with different pathways, including 
protein kinase C (PKC), Rho-associated proteins (ROCK) and p38 mitogen-activated 
protein (MAP) kinase. Currently receiving the most attention is Rho signaling.   
Hypoxia has been shown to increase ROCK activation in smooth muscle cells 
and denuded pulmonary arteries, but the increase is dramatically enhanced by the 
presence of endothelium99.  In addition, recent reports show activation of the Rho-
ROCK pathway in isolated pulmonary artery endothelial cells in response to hypoxia108.   
 
1.1.7.1 Endothelium derived mediators.   
There are several means by which the endothelium could interact with or potentiate the 
calcium changes derived from hypoxic exposure in order to promote a sustained vessel 
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constriction.  This can occur through: a decreases in vasodilator production, an increase 
in vasoconstrictor production or production of a mediator capable of increasing calcium 
sensitivity80.  Potential endothelial-derived mediators of HPV include: nitric oxide (NO), 
adenosine, arachidonic acid metabolites and endothelin, among others.   
 There is currently debate concerning the increased or decreased production of 
the potent vasodilator NO in response to hypoxia.  Since oxygen is required for NO 
production, it would be expected that NO production would decrease in response to 
hypoxic conditions.  It now appears that hypoxia does decrease endothelial derived NO 
production, even when expression of the synthase is increased109.  On the other hand, 
this does not appear be a global response in the lung.  In the microvasculature, where 
shear stress is greatest, NO production may be increased above basal levels80.  A more 
detailed discussion of the role of NO during HPV will be addressed in the next section.     
Evidence indicates that pulmonary endothelial cells release a vasoconstriction 
potentiator.  One of the prominent candidates for this role is endothelin-1 (ET-1), 
although ET-1 receptor antagonists have shown to be ineffective in inhibiting HPV80.  
Further studies have proposed that although ET-1 does not mediate HPV, it may have a 
facilitating role as a priming stimulus, inhibiting KATP channels to induce 
depolarization110. 
Another proposed role for the endothelium during HPV concerns pretone (the 
initial degree of vasoconstriction).  Experimentally, pretone is obtained in isolated 
vessels and whole lung preparations by priming the system with vasoconstrictors like 
angiotensin II or endothelin.  This practice strongly potentiates the effect of HPV.  
Evidence against this theory arises from the fact that unlike the presence of 
endothelium, priming agents are not specifically associated with the second sustained 
response, but enhance both stages111.  
 
1.1.7.2 Endothelial contraction and barrier function in the lung.   
As vessel caliber changes, the smooth muscle layer becomes discontinuous.  Studies of 
rat pulmonary structure in the 1970’s determined that most pulmonary arteries smaller 
than 150µm in diameter only have a partial muscularized layer, which is absent below 
30µm in diameter112.  Videomicroscopy49 and x-ray high-magnification imaging113 have 
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now determined that small (<50 µm in diameter) vessels contract in response to 
hypoxia, suggesting an active contractile response by the endothelium in the lung’s 
microvasculature.   
In contrast to epithelial and smooth muscle cells, endothelial cells are exposed to 
mechanical stress from hydrostatic pressure and cyclic stretch as well as fluid shear 
stress, which stimulates the formation of stress fibers in the same direction as the 
flow114.  This process is Rho dependent, and it is thought to help maintain cell shape 
and a flat surface in order to limit cell surface shear stress gradients115,116.  The induced 
formation of stress fibers in response to Rho and ROCK has been proposed to 
contribute to the maintenance of structural integrity through bearing and distribution of 
forces during contractile events117.  In addition, it has been shown that rat pulmonary 
endothelial cells become stiffer in response to hypoxia, which may also contribute to the 
flatness required to minimize shear stress118. 
Pulmonary endothelial cells have a very important role in maintaining barrier 
function.  In general uncoordinated pairing of adhesive and contractile forces can result 
in gap formation119.  Barrier disruption at the pulmonary level is associated with 
pathological conditions including acute respiratory distress syndrome (ARDS) and 
noncardiogenic edema120.  As previously noted, the rapid increase in intracellular 
calcium in response to hypoxia activates contractile signaling pathways which in the 
lung, may result in increased permeability121.  Specifically, increase in intracellular 
calcium induce MLCK activation, F-actin reorganization and decreased cell-cell and cell-
matrix interactions, which contribute to gap formation and increased permeability in 
different vascular beds122-123.   
In general, both human and rat PMVECs have a predominantly cortical actin 
distribution and form a much tighter monolayer than pulmonary macrovascular 
endothelial cells under basal conditions124-125. In fact, increases in intracellular calcium 
with sarco/endoplasmic reticulum Ca2+ ATPase inhibitor thapsigargin, result in 
increased permeability in the intact lung, as well as changes in pulmonary artery cell 
morphology and barrier function, without affecting permeability in RPMVECs121,126.  In 
general, lung microvascular endothelial cells show less sensitivity to increases in 
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intracellular calcium derived from hypoxic exposure, stimulation of store operated 
calcium entry and release of intracellular stores or ionomycin-induced influx126-128.   
In the context of HPV, recent findings have elucidated the presence of an 
additional signaling pathway activated by hypoxia leading to cytoskeletal changes in 
pulmonary microvascular endothelial cells, which may be acting in parallel with Rho 
signaling.  P38 mitogen activated protein kinase (MAPK) is responsive to stress stimuli 
including hypoxia.  It has been proposed that MAPK-mediated activation of MAPK-
activated protein kinase (MK) 2 results in HSP27 phosphorylation. The small heat shock 
protein HSP27, which is constitutively expressed at high levels in the lung, acts as a 
microfilament capping protein, and its phosphorylation promotes actin polymerization 
and stress fiber formation118,129.  These studies have proposed that while rho-ROCK 
signaling contributes to a contractile response, MAPK signaling promotes stabilization of 
the actin cytoskeleton at the proximity of focal adhesion may provide stabilization 
creating a balance between contractile and adhesive forces in RPMVECs during 
hypoxic exposure118. 
 
 
 
1.2   HYPOXIA AND NITRIC OXIDE (NO) 
 
1.2.1 Nitric oxide biology 
 
Nitric oxide (NO) is a gaseous signaling molecule with multiple biological roles in the 
human body.  NO’s lipophylic nature, allows it to freely diffuse across membranes and 
its high reactivity (half life of 2-5 s) promotes autocrine and paracrine signaling close to 
the point of synthesis. NO has an unpaired electron, making it highly reactive with 
oxygen, superoxide radicals and transition metals130.  NO is found in various redox 
forms: neutral NO●, in reduced state NO- (nitroxyl anion) or oxidized state NO+ 
(nitrosonium). Neutral nitric oxide NO● reacts primarily with oxygen (O2), transition 
metals and free radicals.  Nitroxyl anions spontaneously dimerize as well as interact 
with metals and sulphydryls, while nitrosonium reacts with nucleophilic centers and 
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promote nitrosation.  These interactions confer stability to these highly reactive redox 
forms which have a half life of less than a second (approximately 10-10 s in the case of 
nitrosonium)130-132.  
 Increased interest emerged from NO being identified as the “endothelium-
derived relaxing factor“ (EDFR), which contributed to the recognition of Robert F. 
Furchgott, PhD, Louis J. Ignarro, PhD, and Ferid Murad, MD, PhD as Nobel prize 
winners in 1998.  Currently NO is known to have diverse physiological roles in 
vasodilatation, neurotransmission, cell motility, apoptosis and antiaggregation; with 
most signaling being derived from activation of soluble guanylate cyclase and direct 
inhibition of cytochrome c oxidase in the mitochondria130-131,133.  NO synthesis is highly 
regulated, and associated with cytoprotective as well as toxic end results. 
Therapeutically, this is of great importance in areas like cancer biology, where at high 
concentrations NO promotes nitrosative stress resulting in cell cycle arrest, apoptosis 
and senescence through the formation of nitrogen oxygen species.  Unfortunately, NO 
has also been shown to promote tumor progression through antiapoptotic and 
angiogenic signaling134-135.  In general, cytotoxic effects of NO result from oxidative 
reactions with O2 and superoxide (O2
●-), which result in the formation of nitrite (NO2
-) 
and peroxynitrite (OONO-), which can initiate lipid peroxidation and sulfhydryl 
oxidation136. 
 
1.2.2 NO synthesis 
 
NO is synthesized in a variety of cells, such as endothelial, neurons and macrophages 
by the enzyme nitric oxide synthase (NOS).  There are three canonical isoforms of 
NOS, named after the tissue in which they were originally identified: nNOS (neuronal or 
NOS I), eNOS (endothelial or NOS III) and iNOS (inducible or NOS II).  Under normal 
conditions nNOS and eNOs, also referred as constitutive NOSs (cNOS), continually 
produce NO133.  
Over the last 10 years, researchers have explored the existence of a fourth type 
of NOS, mitochondrial NOS137. Since NOS is encoded by nuclear DNA it is believed that 
every variant must be synthesized in the cytosol and later targeted to the mitochondria.  
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Different groups have reported the presence of eNOS, nNOS and iNOS in either the 
inner or outer mitochondrial membrane with additional variations among tissues138-140. 
Others have proposed that mitochondrial NOS might be an ortholog of AtNOS1 (a plant 
NOS)141.  Most evidence currently points to a nNOS variant, although the subject is still 
under debate142.  The presence of mitochondrial NOS would be of great relevance 
directly modulating respiration at the electron transfer level due to its inhibitory 
interaction with cytochrome c oxidase143.  In addition, studies in yeast, rat liver samples 
and isolated cytochrome c oxidase have suggested that mitochondria might be able to 
generate NO from nitrate starting a hypoxia-induced signaling pathway, again promoting 
localized signaling at subcellular levels144. 
 NOS synthesize NO and l-citrulline from L-arginine in the presence of oxygen 
(O2) and reduced nicotinamide adenine dinucleotide phosphate (NADPH), with the 
requirement of several cofactors and prosthetic groups including thiolate bound heme, 
two flavin mononucleotides (FMN), flavin adenine dinucleotide (FAD) and 
tetrahydrobiopterin (BH4).  Specifically, NO is produced following the reaction: 
 
L-Arginine + 2O2 + 3/2 NADPH + 3/2H
+ = L-citrulline + 2H2O + 3/2 NADP + NO
145  
 
In general NOS proteins are dimers, and each subunit has 3 identical domains: 
1) the reductase domain which transfers electrons from NADPH to the oxygenase 
domain of the opposing subunit; 2) the calmodulin domain, which requires calmodulin 
binding to enable the flow of electrons from the reductase domain; and 3) the 
oxygenase domain, which oxidizes arginine and has a heme binding pocket. 
Ca2+/calmodulin binding in the case of eNOS and nNOS, facilitate the electron transfer 
from the flavins to the heme iron in the oxygenase domain146. 
 
1.2.3 NO signaling 
 
Due to the paramagnetic nature of NO, the different isoforms allow NO to react with a 
wide variety of biological molecules, which can be divided into 3 basic groups: metals, 
thiols and oxides147.  Studies of NO’s interaction with metals has mainly focused on iron 
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binding in the heme group of soluble guanylate cyclase (sGC) and other iron-heme 
containing proteins like cytochrome P450 (in an inhibitory manner)148.  Other metal-
associated targets are cytochrome c oxidase, acontinase and proteins with zinc-thiolate 
clusters like metallothionein149-151. Reaction with thiols is of great importance in proteins 
regulated by formation of S-nitrosothiols (SNO), which include p21ras, hemoglobin, 
caspase-3 and ryanodine receptors147.  The best known reaction of NO with oxides is 
the oxidation of molecular oxygen, which ultimately results in the formation of nitrates 
(with a wide variety of nitrosation targets including the thiols previously described), but 
also of great importance is the interaction with superoxide to form peroxynitrite147.  
Peroxynitrite is a highly reactive oxidant with promotes DNA damage, nitration of 
tyrosine and oxidation of cysteine.  These interactions result in a plethora of 
physiological effects, many of which are associated with pulmonary reactivity and are 
described below. 
 
1.2.3.1 Vasodilatory pathway.   
One of the best known signaling interactions of NO is nitrosation of the ferrous heme in 
soluble guanylate cyclase (sGC).  This reversible interaction promotes conversion of 
GTP into cyclic GMP (cGMP). Elevated levels of cGMP promote cGMP-dependent 
protein kinase activation, which in turn reduces calcium influx, which promotes cell 
relaxation.  In addition, a cGMP-independent pathway appears to contribute to 
vasorelaxation by nitrosylation of intracellular sufhydryl groups resulting in gating 
changes of KCa channels
152 
Globally, decreases in oxygen have been associated with endothelial-derived  
NO production and vasodilatation, which increase blood flow and promote tissue 
oxygenation153. Even at the pulmonary level, almost as soon as NO was identified as 
the EDRF, scientists began to report the use of inhaled NO as a selective pulmonary 
vasodilator154.  Therapeutically it is currently licensed for persistent pulmonary 
hypertension in neonates, but there is a great variability of response between patients 
and there are concerns on its beneficial effect on patient’s outcome155. 
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1.2.3.2 Interaction of NO with the mitochondrial respiratory chain.   
NO has been shown to interact with the terminal enzyme of the mitochondrial 
respiratory chain, cytochrome c, in an inhibitory manner.  The associated inhibition is 
reversible and competes with oxygen143.  This implicates a role for NO in modulating 
cell respiration, although it has been shown that at low oxygen concentrations, NO 
reduces the electron transport without affecting respiration156.  As mentioned in the 
oxygen sensing section, at low oxygen concentrations, NO- cytochrome c interactions 
are associated with release of reactive oxygen species (ROS) and subsequent 
activation of AMP kinase, which are key players in vessel contractility 156-157.    
 
1.2.3.3 Nitrosation of thiols.   
S-nitrosation is a post-translational modification implicated in numerous signaling 
pathways, currently compared to phosphorylation due to its specificity, spatial and 
temporal regulation and reversibility158.  As with phosphorylation, the consequences 
may be inhibitory, like in the case of caspases, or mediate activation as is the case for 
extracellular matrix metalloproteinase MM9159-160. NO nitrosation of cysteine residues is 
called S-nitrosation; the prefix “S-“ stands for sulfur atom where the S-NO bond is 
formed.  In the literature, this same reaction is commonly referred to as S-nitrosylation, 
keeping with the trend of other post-translational modifications like glycosylation and 
phosphorylation161.    
S-nitrosation may occur by transnitrosation or by NO derived nitrosating species 
like dinitrogen trioxide (N2O3). Denitrosation reverses S-nitrosation, especially in the  
reducing environment of the cytosol, for which reason it is thought to be an unstable 
modification162.  Physiologically, S-nitrosation is of great importance, with currently more 
than 100 reported substrates including: p21 ras, caspase, hemoglobin and ryanodine-
sensitive calcium channels133,158. This variety of interactions results in a wide array of 
functions including: anti-apoptotic signaling through s-nitrosation of caspases, 
degradation of extracellular matrix by activation of MMP9 and calcium signaling from 
ryanodine receptor channel opening147,163.  
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1.2.4 NO synthesis in response to hypoxia 
 
Based on the vasodilatory pathway canonically associated with NO, intuitively it would 
be thought that nitric oxide would oppose hypoxic pulmonary vasoconstriction. 
Supporting this idea, studies have shown that pharmacological inhibition of NO 
synthesis doubles the vasocontractile response to hypoxia in isolated perfused mouse 
lungs163-164 and the presence of a stable cGMP analogue attenuates HPV in isolated 
perfused rat lungs165.  In addition, inhibition of NO synthase has been shown to increase 
responsiveness to contractile agents in the airway166.  Finally, the exposure of 
endothelial cells to shear stress promotes NO production, specifically in areas were the 
increase in pressure is greatest (i.e., small resistance arteries)80. These findings also 
support the idea that hypoxia promotes NO synthesis in the lung, even if only in the 
microvasculature80.   
Targeted disruption of the different NOS isoforms determined that eNOS is the 
primary source of NO during HPV167-168. Constitutive NOS isoforms like eNOS may be 
stimulated by calcium dependent and independent ways146  eNOS is targeted to the 
plasma membrane, Golgi complex and caveolae.  It’s presence in caveolae is 
associated with inhibition by binding of caveolin-1, which prevents interaction with 
calcium/calmodulin169.  Activation of eNOS may be mediated by increases in 
intracellular calcium, which promote calmodulin binding and dissociation from caveolin.  
Further regulation is obtained by phosphorylation of at least five regulatory sites which 
are targeted by different kinases, including Akt. AMP, PKA and PKG170-171.  It is worth 
noting that in cases of an absence of oxygen there have been reports of eNOS 
catalyzing the reduction of nitrite to NO172.  
 In addition to the vasodilatory role of nitric oxide, paradoxical evidence supports 
a role in promoting vasoconstriction.  Specifically, it has been shown that addition of NO 
gas in the presence of hemolysate results in a strong sustained vasoconstriction in 
isolated perfused mouse lungs. This process is thought to be associated with NO 
scavenging by hemoglobin, even though the exact mechanism is still under debate173.  
Further evidence of NO contributing to the contractile response to hypoxia in the lung 
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suggests that eNOs inhibition in isolated mouse lungs approximately doubles HPV 
pressure increase167, while cGMP inhibition more than quadruples HPV response174.    
There is also evidence suggestive of increases in NO production in chronic 
hypoxia109. Furthermore, S-nitrosation has been demonstrated to be particularly 
important during prolonged hypoxia in the lung as it has been shown to regulate of 
specific gene expression involving the hypoxia inducible factor (HIF)175.  S-nitrosothiols 
associated with hemoglobin have been shown to stabilize the α-subunit of  the hypoxia-
inducible factor 1 (HIF-1)176.  This in turn increases the expression of vascular-
endothelial growth factors, which may contribute to cellular remodeling and pulmonary 
hypertension. 
 
 
 
1.3   METALLOTHIONEIN AND ZINC 
 
1.3.1 Metallothionein 
 
Metallothionein (MT) is a small, sulfur-rich protein, with high metal affinity, and is 
present in almost all organisms.  Mammals express at least four isoforms (MT-1, MT-2, 
MT-3 and MT-4). In humans there are at least 16 MT genes located in chromosome 16 
and most of them are associated with the MT-1 isoform177. MT-1 and MT-2 isoforms are 
expressed in many tissues and are particularly abundant in the liver, pancreas, intestine 
and kidney178.   MT-3 is expressed in the brain and MT-4 in squamous epithelial cells. 
Globally, most MT is synthesized in liver and kidneys. At the cellular level, MT can be 
found in different cellular compartments as well as is the extracellular space179-180.  MT 
is mostly found associated with zinc within the cell, where it aids in translocation of the 
metal to the nucleus during proliferation and differentiation181. There are also reports of 
MT transport to mitochondria, where it may contribute to respiration modulation through 
the release of zinc179,182. 
Mammalian MT-1 and MT2 are small proteins, (61 and 62 amino acids 
respectively), with a high cysteine content (20 amino acids, ~30%).  The protein is 
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structured in two domains: the α-domain in which eleven cysteines can bind up to four 
zinc atoms and the β-domain with nine cysteines capable of binding three zinc atoms. In 
both domains each zinc atom is bound tetrahedrally to the cysteines183.   Two insertions 
in human MT-3 of six and one amino acids in the α and β domain respectively, and one 
in the  β domain of MT-4 are associated with the functional differences associated with 
these isoforms183. 
 
1.3.1.1 Roles in metal toxicity and redox activity.   
MTs may complex with zinc, copper, cadmium, mercury and silver, among others.  This 
is in concordance with its role in protecting against metal toxicity as well as being an 
important antioxidant183.  MTs are mostly protective against Cd toxicity as was 
established by reduced lethality to a high dose of Cd after increasing production of MT 
with small doses of Zn, Cu, Hg or Cd184.  In addition, MT-null mice are more susceptible 
to Cd-induced lethality while MT-transgenic mice have decreased susceptibility185-186.  
Metallothionein may also protect against the toxicity of other metals to a lesser degree.  
Wild-type mice have a 6.9 fold, 2.4 fold, 1.4 fold and 1.3 fold higher LD50 than MT-null 
mice in response to subcutaneous administration of increasing doses of Cd, Zn, Cu and 
Hg respectively187. 
The affinity for zinc of the different binding sites of metallothionein varies: four are 
high (log K = 11.8), two intermediate (log K ~10) and one low (log K = 7.7)188.  
Physiologically, this allows metallothionein to bind zinc over a wide range of 
concentrations and contribute to its subcellular distribution, while working on a dynamic 
range of zinc loading and redox conditions. The metal thiolate clusters in 
metallothionein are the link between metal concentrations and cellular redox state189.  
The sulfur from the cysteines can be oxidized or reduced, resulting in the release or 
binding of zinc molecules, with the formation or rupture of disulphide bonds183.     
A variety of reactive species promote zinc release from metallothionein including: 
NO and reactive oxygen species, as well as sulfur and selenium compounds189.  Nitric 
oxide has been shown to promote zinc release from metallothionein by S-nitrosation.  
This interaction was proposed over a decade ago, has been confirmed by in vitro 
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assays and most recently by increases in the fluorescent reporter zinquin and  
fluorescence resonance energy transfer (FRET) in pulmonary endothelial cells151,190-191. 
Superoxide, hydrogen peroxide, hydroxyl radicals and peroxynitrite have been 
shown to interact with MT192.  In addition, the resulting zinc release has been shown to 
mediate increased expression of MT-1 and MT-2 though the metal response element-
binding transcription factor (MTF-1)193.  Glutathione disulfide (GSSG) and its reduced 
form glutathione (GSH) contain most of the cell’s non-protein sulfurs and the 
GSH/GSSG ratio is an indicator on the cell’s redox state183. GSSG interaction with MT 
results in zinc release though oxidation, while GSH mediates zinc transfer from 
enzymes to thionein, further linking MT with cellular redox state183.   
 
1.3.2 Zinc biology. 
 
Zinc is the second most abundant trace metal in the human body.  Even though 
the total amount of  zinc in typical eukaryotic cells is in the micromolar range194, free 
zinc concentrations are estimated to be in the picomolar range195-196.  Zinc is widely 
found in enzymes as a catalytic cofactor, serves a structural role in transcription factors 
and is the core of zinc finger domains in proteins.  For this reason, zinc’s roles range 
from metabolism, to gene expression and signal transduction. It is thought that 10% of 
the human genome encodes zinc proteins197.  Since zinc-protein interactions cannot be 
predicted through consensus motifs, this may be an underestimate.   
Globally, 30–40% of zinc is localized to the nucleus, 50% in the cytosol and the 
remainder to membranes. The cellular distribution of zinc is determined by sensors, 
transporters, trafficking and buffering proteins181,196.  It is interesting to note that during 
transport, zinc maintains its valence making it redox inert.  Importers and exporters 
mediate movement across the plasma membrane, while it has been proposed that 
transporters mediate the sequestration of zinc intro intracellular vesicles. There are two 
models of how zinc is moved around in cells: 1) through associative mechanisms, 
constantly being transferred between proteins (without zinc ever being free) or 2) 
through zinc free ions based on dissociation and association between source and target 
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proteins198.  The detection of small, but significant amounts of free zinc in different cell 
types supports the hypothesis of zinc dissociation and association 195-196,199.  
Changes in zinc’s distribution may be triggered by electrical stimulation, DNA 
damage, zinc influx or oxidative pathways, and its release may alter the function of both 
the source and target proteins194.  Currently zinc is starting to be viewed as a second 
messenger acting as a neurotransmitter, mediator of cell-cell signals, regulator of 
transcription factors and modulator of protein function200.  Fluctuations in free zinc are 
associated with the cell’s zinc-buffering capacity and have very important physiological 
and pathological implications.  Most of the zinc buffering in cells is determined by the 
metal-free MT apoprotein thionein, as well as the metallothionein holoprotein.  
Increases in zinc induce synthesis of thionein, which contributes to zinc buffering, 
aiming to restore homeostasis194.  
Zinc is a pro-antioxidant in that its binding to thiols and membrane lipids protects 
them from irreversible oxidation201.  In addition, increased zinc concentration stimulates 
the production of more thionein, each one with 20 thiols with antioxidant capacity202.  
Zinc deficiency is of great concern in developing countries and the elderly because of 
the restricted intake of protein rich foods203.  This metal’s deficiency is associated with 
growth retardation, depressed immunity, sickle cell disease, diabetes, skin lesions and 
many other illnesses.   
Excess consumption of zinc is associated with protein misfolding because of its 
strong interaction with proteins204.  When zinc can no longer be buffered it may become 
a pro-oxidant through increased oxidative stress.  At high concentrations, zinc may 
become neurotoxic resulting in ataxia and lethargy, presumably due to inhibition of 
mitochondrial respiratory enzymes 205.  Zinc has been shown to interact with the four 
complexes of the respiratory chain with different affinities and thus, MT’s localization to 
mitochondria could contribute to zinc’s inhibition of respiration 206,183. 
 
1.3.3 Zinc and lung disease. 
 
Zinc deficiency, common in infants and children in developing countries as well as in the 
elderly, is currently being proposed as a risk factor for pneumonia207-208.  Recent studies 
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have shown a significant decrease in the incidence of infection (including acute lower 
respiratory infection) with zinc supplementation in both age groups209-212.  The 
decreased incidence of infection has been proposed to result from improved T cell-
mediated function and decrease in pro-inflammatory cytokines or lipid oxidation207.   
Studies in rats with low zinc diets show enlarged lungs due to increased 
connective tissue, edema and polymorphonuclear neutrophil infiltration201.  Two months 
of a zinc-deficient diet in mouse models, show a slightly increased production of MT and 
increased activity and expression of iNOS and (cyclooxygenase-2) COX-2201.  Both 
iNOS and COX-2 are inflammatory and immunologic mediators213.  There is evidence 
that these signaling pathways are co-induced and that nuclear factor-ĸB (NF- ĸB) 
controls their expression214.  The increased expression of iNOS and COX-2, results in 
increases in NO and prostaglandins which contribute to the oxidative damage and 
inflammatory cell infiltation215.  NO in the presence of superoxide results in the formation 
of peroxinitrite which has been associated with inhibition of surfactant function by lipid 
peroxidation.  In addition, there is evidence of zinc having an important role in cell-cell 
interactions and maintenance of barrier function in both pulmonary endothelial and 
epithelial cells216-217.  Further research is needed to determine how the plethora of 
pathways associated with zinc signaling may be contributing specifically to HPV. 
  
 
 
1.4 RATIONALE 
 
Hypoxic pulmonary vasoconstriction is an intrinsic response that optimizes gas-
exchange by re-directing blood flow to areas of greater oxygen availability19.  This 
phenomenon is beneficial to the fetus as it diverts blood flow from the unventilated 
alveoli into the ductus arteriousus, and in adults during local airway obstruction and 
atelectasis72.  However, constant or intermittent global hypoxic exposure in the range of 
days to months in adults may lead to pathological conditions such as pulmonary 
hypertension and edema107.   To date, the majority of the research in the area of HPV 
has concentrated on delineating the oxygen sensing and signal transduction pathways 
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leading to vascular smooth muscle cell contraction and their contribution to changes in 
pulmonary arterial pressure.  It is clear that pulmonary vascular smooth muscle cells are 
capable of sensing changes in oxygen tension in the alveoli, activating calcium-
dependent pathways and increasing actin-myosin interactions to promote cellular 
contraction68.  On the other hand, the pulmonary endothelium is thought to primarily 
fulfill a modulatory role in HPV through the actions of various endothelial-derived 
mediators80.  For example, it has been proposed that the release of a yet unidentified 
agent from the endothelium activates calcium sensitization pathways, which enables a 
prolonged increase in perfusion pressure in small intrapulmonary arteries, while 
intracellular calcium levels have stabilized at above normal values75,218.     
Hypoxia promotes a heterogeneous contractile response throughout the 
pulmonary vascular bed, with the greatest increases in resistance occurring in arterial 
segments of less than 300µm in diameter45-46.  There is also evidence of the reactivity of 
small resistance vessels of less than 50μm in diameter, composed primarily of 
endothelial cells and shown to lack a continuous smooth muscle layer49,113.  These 
observations suggest that the endothelium can contribute to changes in vessel tone, as 
has been reported in cardiac capillaries in response to ischemia/reperfusion219-220.  
Inhibition of NO signaling, either through pharmacological or genetic inhibition of 
NOS activity, indicates that NO production is increased in response to acute 
hypoxia163,221.  NO induces increases in labile zinc in isolated pulmonary endothelium, 
through post-transcriptional modification of the zinc-binding protein metallothionein 
(MT)191.  The relevance of the NO/MT/Zn pathway was described initially in the systemic 
vasculature, where the mesenteric myogenic reflex was found to be absent in MT -/- 
mice unless NO synthesis was pharmacologically blocked using the NOS inhibitor L-
NAME151.  In MT null animals, NO formed in response to increased intraluminal 
pressure promoted greater relaxation in comparison to wild-type animals, suggesting an 
effect downstream of MT that opposes vasodilation151,222.  This led us to investigate 
whether the NO released in response to acute hypoxia could result in a physiologically 
relevant vasoconstriction in the lung through a NO/MT/Zn-derived pathway.  
Specifically, pulmonary arterial pressure and changes in diameter of small intraacinar 
vessels of the lung in response to hypoxia were measured. Also, it was confirmed that 
 29 
the hypoxia-induced S-nitrosation of MT and changes in intracellular zinc homeostasis 
using a combination of fluorescent reporter molecules in both live cells and the isolated 
perfused mouse lung.   
Zinc deficiency has been associated with alterations in endothelial and epithelial 
barrier function in the lung, suggesting a role for the metal in maintaining cytoskeletal 
stability216-217.  In addition, exogenous zinc was shown to increase the amount of F-actin 
in epithelial cells (MDCK) and potentiate contraction in skeletal muscle, further 
suggesting an association between zinc and cell contraction223-224. Endothelial cell 
shape is determined by a balance between contractile forces derived from actin-myosin 
interactions and cellular tethering by focal adhesions225.  Tension generation is 
determined by the level of phosphorylation of the myosin light chain (MLC), which is in 
turn dependent upon the balance between the activities of MLC kinase (MLCK) and 
phosphatase (MLCP).  Several inhibitory interactions have been reported between Zn 
and MLCP which may lead to increased MLC phosphorylation and cellular 
contraction226-227.   Specifically, zinc has been shown to have an inhibitory effect on 
various phosphatases, including PP1 (found at the catalytic core of MLCP), as well as to 
directly activate MLCK in vitro226,228.  Furthermore, zinc has also been reported to 
regulate protein kinase isoforms associated with cell contraction, which have been 
shown to play a role in HPV (PKCε)229.   
It was hypothesized that the NO generated in response to acute hypoxia in 
pulmonary endothelium may promote cellular contraction through MT-dependent 
increases in labile zinc, resulting in alteration in MLC phosphorylation and actively 
regulating HPV.  The thesis was directed towards the relevance of the endothelial 
NO/MT/Zn signaling pathway in mediating vasoconstriction of small intraacinar arteries 
of the lung, along with the downstream signaling pathways by which zinc might 
contribute to changes in cell shape and presumably vessel diameter via phosphorylation 
of key contractile proteins, to affect increases in actin-myosin interactions and 
cytoskeletal stability in the pulmonary endothelium (Figure 2).   
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Figure 2. NO related signaling pathways modulating hypoxic pulmonary 
vasoconstriction. Increased intracellular calcium in conjunction with hypoxia induced changes 
in shear stress activated eNOS.  The resultant increases in NO synthesis promote vasodilation 
through inhibition of calcium dependent potassium channels and activation of cyclic GMP 
(cGMP). NO may also contribute to hypoxia-induced vasoconstriction, via S-nitrosation of the 
metal-binding protein, metallothionein (MT), and associated changes in intracellular labile zinc. 
MT-released zinc promotes cell contraction through inhibition of (myosin light chain 
phosphatase) MLCP resulting in accumulation of phosphorylated myosin light chain (MLC) and 
formation/stabilization of actin stress fibers 
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2 MATERIALS AND METHODS 
 
 
 
2.1 CHEMICALS AND MATERIALS 
 
All reagents were purchased from Sigma-Aldrich (www.sigmaaldrich.com) unless 
otherwise noted. The GFP-dominant negative PKCε herpes simplex virus was provided 
by Joseph Glorioso 230. 
 
 
 
2.2  ANIMAL AND CELL MODELS 
 
All studies were approved by the Institutional Animal Care and Use Committee (IACUC) 
at the University of Pittsburgh and following the guidelines of the American Physiological 
Society. 
 
2.2.1 Mouse and rat strains 
 
Sprague Dawley rats; Tie2-Green Fluorescent Protein(GFP) mice (STOCK 
Tg(TIE2GFP)287Sato/J); MT -/- (129S7/SvEvBrd-Mt1tm1BriMt2tm1Bri ) and WT controls 
(129S1/SvImJ, MT +/+) were purchased from Jackson Laboratories (Bar Harbor, ME).   
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2.2.2 Isolated Perfused Mouse Lung  
 
Mice were anesthetized, heparin was injected i.v. (50 U) and a thoracotomy performed 
to expose heart and lungs. The trachea was cannulated and heart and lungs removed 
en bloc. Catheters were placed in the pulmonary artery and left atrium.  Lungs were 
perfused via a peristaltic pump (0.8 ml/min) with a modified Krebs Henseleit solution 
supplemented with 5.0 M meclofenamate and 5% dextran.  Heart/lungs were then 
transferred to a glass bottomed humidified temperature controlled chamber.  During 
image acquisition, ventilation was stopped and the lungs held statically inflated. 
Perfusion pressure was monitored and recorded at constant flow (PowerLab, 
ADInstruments, Inc., Colorado Springs, CO). After establishing a baseline perfusion 
pressure with 21% O2, lungs were inflated with the hypoxic gas mixture (1.5% O2, 5% 
CO2, and balance N2) for 10 min followed by a return to 21% O2.
 The use of 1.5% O2 
resulted in a drop in PO2 from 100-110 mmHg to ~30-35 mmHg as measured in the 
venous effluent using a Clarke electrode. 
 
2.2.3 Isolated Perfused Rat Lung 
 
Male rats (300-350g) were anesthetized, injected i.v. with heparin and a thoracotomy 
performed to expose heart and lungs. Rats were ventilated (model 683, Harvard 
Apparatus, Holliston, MA) at 55 breaths/min with tidal volumes less than 10 cm H2O. 
The pulmonary artery and left atrium were cannulated, and the ventilator set to 2 
cmH2O of positive end expiratory pressure (PEEP). Lungs were perfused at 3ml/min 
with warmed Krebs-Henseleit Buffer supplemented with 3% Ficoll, 3.1 M 
meclofenamate and 2.8 mM CaCl2. The preparation equilibrated for 15 min followed by 
priming with 100 ng angotensin II via bolus injection. The IPL was then exposed to three 
successive 5 min episodes of alveolar hypoxia separated by 5 min recovery. The 
perfusate was then switched to buffer containing 25 M TPEN and the responses to two 
repeated hypoxic episodes were examined. Finally, the IPL was again exposed to two 
successive hypoxic episodes following removal of TPEN from the perfusate. 
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2.2.4 Cell cultures 
 
Cultures were grown at 37°C in an atmosphere with 5% CO2.  Mouse lung endothelial 
cells (MLEC)231 and sheep pulmonary artery endothelial cells (SPAEC)191 preparations 
are described elsewhere. Rat pulmonary microvascular endothelial cells (RPMVEC) and 
rat aortic endothelial cells (RAEC) were purchased from VEC Technologies Inc. 
(Resselaer, NY) and grown in complete MDCB-131 media (VEC Technologies Inc).  Rat 
pulmonary artery endothelial cells (RPAEC) were grown in Dulbecco Modified Media 
(Fisher Scientific) with 10% fetal bovine serum, 2 mM glutamine, and 100 U/ml 
penicillin/streptomycin. 
 
 
 
2.3 ANALYSIS OF CONTRACTILE BEHAVIOR 
 
Matrices were prepared on 40 mm coverslips using rat tail (BD Bioscience, Bedford 
MA), or bovine (PureCol, INAMED, Fremont, CA) type 1 collagen. RPMVEC and RAEC 
were seeded on the matrix 24 hours prior to imaging. Cells were imaged in a closed, 
thermocontrolled (37ºC) stage insert (Bioptechs, Butler, PA) under continuous flow of 
media at 0.3ml/min, resulting in approximately 8dyn/cm2 of shear stress (KDS 100 
syringe pump, KD Scientific, Holliston, MA). Images were obtained using a Nikon 
TE2000E microscope equipped with a 40X 1.3NA oil immersion objective  After 
collection of baseline images, cells were exposed to perfusate that had been bubbled 
with anoxic gas (95% N2, 5% CO2) which  acutely reduces oxygen tension to 13 ± 2 
mmHg,. Although changes in cell shape are easily quantified, they do not distinguish 
between active contractile events and passive changes due to alterations in cellular 
anchoring. During active contraction, the cell exerts force on the surrounding matrix 
allowing us to use differential interference contrast (DIC) images of intrinsic collagen 
fiber structure, combined with online Deformation Quantification and Analysis (DQA) 
software (http://dqa.web.cmu.edu)232, to distinguish between active vs. passive events 
by examining  collagen displacement.   
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2.4   IMAGING TECHNIQUES 
 
2.4.1 Immunofluorescence 
 
Cells were seeded on glass coverslips coated with Laminin (11.34µg/ml, Fisher 
Scientific). Following the prescribed treatment, the cells were washed with PBS, fixed, 
and permeabilized in 2% paraformaldehyde with 0.1% Triton-X100. In the case of 
hypoxic exposures, these steps were performed inside an hypoxic chamber (Coy 
Laboratory Products, Grass Lake, MI).  Sequential XYZ-sections (1024X1024 pixels, at 
Nyquist axial frequency) were obtained using an Olympus Fluoview 1000 confocal 
microscope (Bethlehem, PA) equipped with a 60X oil immersion optic (NA, 1.43). The 
3D architecture of the cells was reconstructed using Metamorph software (Molecular 
Devices, Downingtown, PA); and quantification of actin stress filaments was determined 
by volume rendering in Imaris (Bitplane, Saint Paul, MN). 
 
2.4.2 Live cell imaging 
 
Cells were seeded on 35mm laminin coated glass bottom dishes (MatTek Corporation, 
Ashland, MA) and imaged in a closed, thermo-controlled (37ºC) stage top incubator 
(Tokai-Hit, Tokyo, Japan). Images were obtained using a Nikon TE2000E (Melville, NY) 
microscope equipped with a 40X oil immersion objective (Nikon, CFI PlanFluor, NA 1.3) 
and Q-Imaging Retiga EXI camera (Burnaby, BC, Canada).  Metamorph (Molecular 
Devices, Downingtown, PA) was used to collect and analyze data and to drive the 
microscope.   Hypoxic conditions were obtained by bubbling the media with hypoxic gas 
(90% N2, 5% CO2, and 5% O2) which reduced oxygen tension to 15 ± 2 mmHg, as 
measured using a Clarke electrode. For each experiment, images were collected from a 
minimum of five different positions from at least three different subcultures of cells. 
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2.4.3 Imaging with calcium and zinc sensitive Fluorophores 
 
FluoZin-3 (2.5 M) was added to the perfusate and murine lungs continuously perfused 
for 20 minutes, followed by a 20 min washout period. The basal surface of the lung was 
placed in close proximity to a 40X oil immersion objective (PlanNeoFluar, NA 1.3) for 
confocal imaging (510META, Carl Zeiss, Jena, Germany). FluoZin-3 was excited using 
the 488 nm line of the argon laser and emissions detected using a 505- to 550-nm 
bandpass filter. Sequential XYZ-sections which included the entire vessel were 
collected during hypoxic exposure and the three-dimensional anatomy of the 
vasculature was reconstructed using MetaMorph (Molecular Devices, Sunnyvale, CA).    
 
2.4.4 Fluorescence Resonance Energy Transfer 
 
Details regarding the FRET constructs, cygnet-2233 and FRET.MT151,234 were reported 
previously. FRET was detected in cell culture using spectral confocal microscopy (Zeiss 
510META, Carl Zeiss, Jena, Germany)234. In brief, color separation of the donor (ECFP) 
and acceptor (EYFP) emission spectra was determined from the resolved image using a 
linear unmixing algorithm based on reference spectra obtained in cells expressing only 
ECFP or EYFP. Changes in the emissions ratio of the acceptor (EYFP, ~525 nm) to the 
donor (ECFP, ~480 nm) were monitored following exposure to hypoxia. In separate 
control experiments, FRET was confirmed by acceptor photo-bleaching 234. 
 
2.4.4.1 FRET in the IPL 
FRET expression was achieved in pulmonary endothelium of the mouse via tail vein 
injection of DOTAP:cholesterol liposomes 235 followed by 50 g cygnet-2 plasmid (at a 
1:5 -/+ charge ratio) or adenovirus containing cDNA for FRET.MT. Pulmonary 
adenoviral mediated somatic gene transfer was shown to be significantly improved by 
pre-injection of cationic liposomes235. FRET was detected in real time, using spectral 
confocal imaging of the intra-acinar arteries of the IPL. Images were obtained with the 
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40X oil immersion optic at 512 × 512 pixels. Acceptor photo-bleaching confirmed that 
the FRET.MT reporter was functional in the intact tissue (data not shown). 
 
2.4.5 TIRF imaging.  
 
Cells were imaged on a Nikon TiE inverted microscope (Melville, NY) with a 1.49 NA oil 
immersion objective capable of both epifluorescence and TIR-FM illumination through 
the objective. EGFP was excited with a 488nm Coherent Sapphire laser (Coherent Inc., 
Santa Clara, CA). Laser intensities were controlled using a Neos AOTF mounted on a 
Prairie Technologies laser bench (Madison, WI).  To ensure correct image registration a 
triple pass filter cube (488nm,561nm, 638nm) and matched emitter filters were used 
(Chroma, Brattleboro VT).  Images were collected using a Photometrics HQ2 Coolsnap 
camera (Photometrics, Tucson AZ) at full resolution. Data was collected and analyzed 
using NIS-Elements (Nikon Corp., Melville, NY).  
 
 
2.5 PROTEIN PHOSPHORYLATION AND ENZYMATIC ACTIVITY 
 
2.5.1 Membrane fractionation. 
 
Cells were lysed (100 mM Tris·HCl, pH 7.4, 1%, v/v Nonidet P-40, 10 mM NaF, 1 mM 
vanadate, 10 μg/ml of aprotinin, 10 μg/ml of leupeptin) and centrifuged for 10 m at 
14000 rpm. The supernatant was further centrifuged at 43,000 x g for 30 m 236. The 
resulting supernatant was then used as the cytoplasmic fraction and the resuspended 
pellet as the membrane fraction. Protein concentrations were determined using Lowry’s 
assay to allow for equal gel loading and at least 15 µg total protein per fraction was 
used for Western blot analysis. 
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2.5.2 PKCε immunoprecipitation and enzyme activity assay. 
  
 Cells were lysed in modified RIPA buffer (100 mM Tris·HCl, pH 7.4, 1%, v/v, Nonidet-
P40 10 mM NaF, 1 mM vanadate, 10 μg/ml of aprotinin, 10 μg/ml of leupeptin). 
Insoluble material was removed by centrifugation and protein concentrations 
determined using the Bio-Rad DC protein assay. Equal amounts of protein were 
precleared with protein A-Sepharose and then incubated with monoclonal PKCε 
antibody for 2 h at 4 °C. The immune complexes were isolated with Protein A-
Sepharose, washed and eluted. Equal amounts of immunocomplex were then subjected 
to PKCε kinase assay, as described previously 237.  In brief, the assay was carried out 
by coincubating 20 μl of immunoprecipitated PKCε with 50 μM ATP, 5 μg of 
phosphatidylserine, 40 μM PKCε substrate peptide (a preferred substrate of PKCε, 
Upstate Biotechnology, Lake Placid, NY), 0.2 μl of [32P]ATP (Perkin Elmer Life and 
Analytical Sciences, Boston, MA) in a final volume of 50 μl. The reaction was allowed to 
proceed at 30°C for 10 min. An aliquot of the reaction mixture was then spotted on p81 
paper, washed in 5% acetic acid, and counted in a scintillation counter. 
 
 
 
2.6 STATISTICAL ANALYSIS. 
 
Results are given as mean ±SD. Data were analyzed using a one-way analysis of 
variance for multiple comparisons with post-hoc Tukey tests for pairwise comparisons. 
Comparisons between more than two groups were done using one-way ANOVA test 
followed by Dunnett’s post-test. Significance was set at P < 0.05. 
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3 NITRIC OXIDE MEDIATES ZINC RELEASE CONTRIBUTES TO HYPOXIC 
REGULATION OF PULMONARY TONE 
 
 
 
3.1 INTRODUCTION 
 
Acute hypoxic pulmonary vasoconstriction (HPV)238 is unique to the pulmonary vascular 
bed and is an important mechanism for matching blood flow to ventilation thereby 
preventing arterial hypoxemia. Reductions in oxygen tension and associated changes in 
vascular resistance have been associated with increased endothelium-derived nitric 
oxide (NO)168 . In the systemic circulation, this is believed to contribute to hypoxic 
vasodilatation, whereas in the lung, NO biosynthesis will oppose hypoxic 
vasoconstrictor stimuli via activation of the soluble guanylyl cyclase (sGC)/ 3',5'-cyclic 
guanosine monophosphate (cGMP) pathway or by directly opening KCa2+ channels in 
pulmonary vascular smooth muscle221,239.  
 In addition to covalent modification of heme or non-heme iron, NO may exert 
significant biological activity via S-nitrosation of thiol groups. The zinc-thiolate moieties 
of the metal binding protein, metallothionein (MT) are critical targets for NO151,190,  
directly affecting  intracellular zinc homeostasis 190,7.  While the physiological relevance 
of NO-induced changes in labile zinc is unknown, interactions between NO and MT 
facilitate myogenic reactivity in systemic resistance vessels 151.  Indeed, while calcium 
has a well-documented critical role in pulmonary vasoregulation, little is known about 
the role of the other major divalent cation, zinc. 
Contemporary optical microscopy and fluorescent reporter molecules were used in 
live cells and isolated perfused lungs (IPL) of rats and genetically modified mice, to 
investigate the role of NO-induced changes in labile zinc on pulmonary vasoregulation. 
The current data indicates that hypoxia-induced acute increases in NO synthesis, in 
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addition to opposing HPV via activation of sGC or direct activation of KCa2+ channels, 
contributes to vasoconstriction in pulmonary resistance vessels via S-nitrosation of the 
metal binding centers of MT and alterations in intracellular zinc homeostasis.  
 
 
 
3.2 RESULTS 
 
3.2.1 Hypoxia causes active constriction of vessels in the isolated perfused mouse 
lung 
 
The Tie2-GFP mouse expresses GFP under control of endothelial-specific receptor 
tyrosine kinase (Tie2) promoter and hence defines the vascular bed. Confocal laser 
scanning microscopy penetrates about 100 m into tissue allowing visualization of intra-
acinar pulmonary arteries in murine IPL. Figure 3A (left) shows a three dimensional 
reconstruction of 46 and 41 m segments of an intra-acinar pulmonary artery. At 15 min 
after exposure to hypoxia, each segment decreased to a diameter of 39 m (Figure 3A, 
middle) and returned to control values (48 and 42 m; right) during recovery in 
normoxia.  In repeat experiments (n=5, 3-5 vessels per experiment), there was a 9.2 ± 
1.1% (P < 0.001) decrease in diameter in these small arteries (≤40 m) in response to 
hypoxia. 
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Figure 3. Hypoxia causes active 
vasoconstriction of intra-acinar 
arteries in the isolated perfused 
mouse lung.  A. Confocal images of 
intra-acinar arteries of the IPL from a 
Tie2-GFP mouse at baseline, after 10 
min of hypoxia, and after 10 min of 
recovery.  B.  The 9.7 +/- 2.0 % change 
in perfusion pressure was accompanied 
by a 9.2 ± 1.1% (P < 0.001) decrease in 
vessel diameter (≤40 µm) in response 
to hypoxia (N=5, with 3 to 5 vessels per 
experiment). 
 
3.2.2 Isolated pulmonary microvascular endothelial cells contract in response to 
hypoxia. 
 
Desmin staining (Figure 4) is consistent with data from other species, including rats, 
showing that the smooth muscle component of small pulmonary arteries (< 100 m) is 
either absent, or is discontinuous in comparison to larger vessels112,240 raising the 
possibility that endothelium contributes to the observed constriction in intra-acinar 
arteries of the IPL. Indeed isolated pulmonary endothelial cells do contract reversibly in 
response to hypoxia. Hypoxic exposure induced a 30%  15.1%  reduction in surface 
area in RPMVEC followed by a 25%  18.9% recovery on return to normoxia (Figure 
5A, n=26). Conversely, RAEC (n=8) constrict with thrombin but not hypoxia (Figure 5A 
and Figure 6), illustrating that, like HPV, the hypoxia-induced contractile response is 
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unique to endothelial cells derived from lung. To confirm that cells are actively 
contracting rather than undergoing passive shape changes, the collagen matrix 
deformation resulting from cell-applied forces was examined (Figure 5B). The DQA 
software analyses single cell mechanics by tracking material displacement between 
time lapse images to create 2D density maps (Density Analysis) and continuous vector 
fields (Strain Analysis)  as shown in Figure 5B.  The resulting patterns were consistent 
in all RPMVEC examined (n=26) demonstrating tension exerted by cells as they 
contract during hypoxia.  
 
 
Figure 4.   Confocal imaging of a fixed section of lung from a Tie2-GFP mouse. 
Endothelium appears green. Red shows desmin staining to demark the smooth muscle layer. 
Blue is DAPI staining of cell nuclei.  Scale bar is 20 µm. A continuous medial layer of smooth 
muscle (e.g. immunoreactive desmin positive) was apparent in vessels >100 m.  However, in 
vessels <100 µm  immunoreactive desmin was heterogeneous in nature and appeared as 
discrete, discontinuous or solitary like cells in the mural wall of the Tie2-GFP positive 
endothelium.   
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Figure 5. Isolated rat pulmonary 
microvascular endothelial cells 
(RPMVEC) contract in response 
to hypoxia. A. RPMVEC embedded 
in a collagen matrix showed a -30% 
 15.1% decrease in surface area 
upon exposure to hypoxia and a 
25%  18.9% increase during 
recovery. In contrast, rat aortic 
endothelial cells (RAEC) did not 
respond to hypoxia. B. Single cell 
mechanics were analyzed by 
tracking material displacement 
between time lapse images to 
create the 2D density increment 
(Density Analysis) and continuous 
vector field (Strain Analysis) shown 
in the right hand panels232.  The 
black area shows the area where 
the cell is located.  Positive principal 
strains, representing extension, are 
coded blue, and negative principal 
strains, representing compression, 
are coded red. The pure tension 
(Strain Analysis, blue vectors) 
exerted by the cell as it contracted 
during hypoxia resulted in a 
decrease in collagen density in the 
area of retraction (Density Analysis, 
blue areas). The medial increases 
in collagen density (Density 
Analysis, red areas) are a result of 
localized compression of the matrix 
(Strain Analysis, red arrows). 
Relaxation during the normox c recovery period was accompanied by radial decreases in 
collagen density (Density Analysis, blue areas) in the area immediately adjacent to the cell body 
as it spread and pulled for anchorage (Strain Analysis, blue arrows). The regions surrounding 
the cell showed an increase in collagen density (Density Analysis, red areas) resulting from 
radial compression forces (Strain Analysis, red arrows) exerted by the cell pushing against the 
collagen matrix.  
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Normoxia Thrombin Normoxia Hypoxia
 
Figure 6. Contraction analysis of rat aortic endothelial cells. In contrast to the hypoxia-
induced contraction observed in rat pulmonary microvascular endothelial cells (RPMVECs), rat 
aortic endothelial cells (RAECs) did not respond to hypoxia but constricted normally to thrombin, 
illustrating that, like HPV, the hypoxia-induced contractile response is unique to lung.  
 
 
3.2.3 Acute hypoxia cause NO-dependent increases in labile zinc in the mouse IPL, 
and in endothelial cells.   
 
The effects of hypoxia on intracellular zinc were initially studied in primary cultures of 
MLEC. Exposing cells to hypoxic media caused NOS-dependent increases in labile zinc 
evidenced by increased fluorescence intensity of FluoZin-3 (Figure 7). To establish the 
relevance of the hypoxia-NO-zinc signaling pathway in the intact organ, confocal 
microscopy was used to image FluoZin-3 in vasculature of IPL of MT +/+ mice. 
Detected fluorescence was significantly increased during hypoxia (Figure 8A, upper 
panel) but prevented by the NOS inhibitor L-NAME, 1mM (Figure 8A, middle panel). 
Furthermore, the IPL of MT-null mice showed no evident changes in fluorescence in 
response to hypoxia (Figure 8A, lower panel) suggesting changes in intracellular zinc 
were critically dependent upon both NO production and metallothionein (Figure 8B). 
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Figure 7.  Acute hypoxia cause NO-dependent increases in endothelial cell culture. 
Mouse lung endothelial cells (MLEC) were imaged in a closed, thermocontrolled (37ºC) stage 
insert (Bioptechs, Butler, PA) that allowed continuous flow of media at 0.3ml/min, resulting in 
approximately 8dyn/cm2 of shear stress (KDS 100 syringe pump, KD Scientific, Holliston, MA). 
Images were obtained using a Nikon TE2000E microscope equipped with a 40X oil immersion 
objective (Nikon, CFI PlanFluor, NA 1.3). Emission imaging of FluoZin-3 was accomplished 
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using a FITC longpass filter set (Chroma, Rockingham, VT) and collected with a CoolSNAP HQ 
CCD camera (Photometrics, Tucson, AZ) and MetaMorph software (Molecular Devices, 
Downington, PA).  After collection of baseline images (A), cells were exposed to perfusate that 
had been bubbled with anoxic gas (95% N2, 5% CO2) that was shown to acutely reduce oxygen 
tension to 13 ± 2 mmHg, as measured in the outflow using a Clarke electrode, resulting in a 
time dependent increase in FluoZin-3 fluorescence (B) which was reversed by TPEN (C). 
Treatment with the NOS inhibitor, L-NAME blunted the hypoxia-induced increases in 
fluorescence (D). These effects were partially reversed by L-, but not D-Arginine (D).  Mean 
data represent three experiments per condition (three to five cells per experiment). * 
Significantly different from hypoxia alone, P < 0.001. 
 
Figure 8.  Hypoxia increases 
labile zinc in the isolated 
perfused lung (IPL). Confocal 
microscopy was used to image 
FluoZin-3 fluorescence in 
reconstructed vasculature of mouse 
IPL. FluoZin-3 fluorescence was 
increased during hypoxia in the MT 
+/+ lungs (A, upper panel) whereas 
IPL of MT-null mice showed no 
significant change (A, middle panel). 
NOS inhibition (L-NAME, 1mM) 
prevented hypoxia-induced changes 
in fluorescence in MT +/+ lungs (A, 
lower panel). Results were 
reproducible in separate 
experiments on 3-5 mice per 
condition (B). * Emissions increased 
above baseline levels, P < 0.001. 
Calibration bar equals 50 µm. 
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3.2.4 Zinc chelation attenuates HPV in the isolated perfused lung 
 
The isolated effect of altered zinc homeostasis on HPV was examined further using 
TPEN. Figure 9A shows representative pulmonary arterial pressure tracings from the 
IPL of a Tie2-GFP mouse. Addition of TPEN (25 M) to the perfusate attenuated the 
hypoxia-induced increase in pressure (Figure 9A, lower panel). Blunting of HPV by 
TPEN was both reproducible and significant (P < 0.05, n=5) (Figure 9B). In contrast, the 
pressor response to 1 M U46619 (an increase of 3.1 + 0.8 cm H2O) was not affected 
by TPEN (an increase of 2.8 ± 0.8 cm H2O).  
  
Figure 9.  Zinc chelation attenuates hypoxic pulmonary vasoconstriction (HPV) in the 
isolated perfused lung (IPL).  Panels A and C show representative pressure tracings from a 
mouse and rat IPL, respectively. TPEN (25 M) attenuated (P < 0.05) HPV in both species (n=5 
for mice, B and n=6 for rats, D).  
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 The effects of zinc chelation on HPV in rat IPL were also examined (Figure 9C 
and D, n=6). As was the case in the mouse IPL, HPV was attenuated by TPEN (mean 
pressure change in hypoxia 1.6 ± 0.2 vs. 0.7 ± 0.3 cm H2O with TPEN, P < 0.05), and 
this effect was reversed when TPEN was removed (mean pressure change upon re-
exposure to hypoxia, 1.3 ± 0.3 cm H2O). The hypoxic pressor responses in both the 
mouse and rat IPL were found to be modest. Nonetheless, the effects of zinc chelation 
on HPV were apparent in the two species and were shown to be reversible suggesting 
that the proposed NO-zinc signaling pathway is physiologically relevant. 
  
3.2.5 Hypoxia regulates both cygnet-2 and FRET.MT function suggestive of increased 
NO production and nitrosation of MT, respectively. 
 
The St Croix lab had previously described 234 the use of genetically-encoded  FRET 
reporters to detect NO-related protein modifications including: (a) S-nitrosation, via the 
cysteine-rich protein metallothionein (FRET.MT); and (b) nitrosyl–heme–Fe, via 
guanosine 3′,5′-cyclic monophosphate (cygnet-2). These approaches were used during 
hypoxic exposure in live endothelial cells. Hypoxia was associated with a significant (P 
< 0.05) decrease in the FRET ratio for both reporter molecules (Figure 10) that was 
complete within 4 min. It was previously shown that FRET.MT is sensitive to NO donors 
as well as endothelial NO synthase (eNOS)-derived NO 151,191,234. The effects of hypoxia 
on FRET.MT were significantly blunted by NOS inhibition (Figure 10B) further 
demonstrating a role for NO in this response. The hypoxia- induced decrease in energy 
transfer observed with the cygnet-2 reporter (Figure 10C and D) was consistent with 
increases in cGMP, as previously reported in response to activation of sGC by NO 
donors 233,234. Furthermore, NOS inhibition (P < 0.01) attenuated the changes (Figure 
10D) indicating the importance of hypoxia-induced NO generation in mediating the 
responsiveness of cygnet-2. 
 These NO-mediated events were confirmed in the intact tissue using spectral 
confocal imaging of buffer perfused lungs expressing the FRET.MT or cygnet-2 
reporters. Expression was confined to small intra-acinar arteries and was predominantly 
endothelial as shown in Figure 11A (FRET-MT). In agreement with the cell culture data, 
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hypoxia induced decreases in energy transfer for both reporters (Figure 11D). These 
changes in FRET were evidenced by increases in the peak emission intensity of the 
donor and decreases in that of the acceptor (Figure 11B and C). The changes for 
FRET.MT were consistent with conformational changes and release of metals from the 
thiolate clusters of the core metallothionein protein as supported by hypoxia-induced 
increases in labile zinc (Figure 9). 
 
Figure 10. Hypoxia regulates FRET.MT and cygnet-2 function in sheep pulmonary artery 
endothelial cells (SPAEC).  Representative spectral reports for single cells  (A and C) show 
the decrease in energy transfer following hypoxic exposure as evidenced by an increase in the 
emission intensity of the donor (cyan) and a decrease in that of the acceptor (yellow). The mean 
data (± SD) for three separate experiments (2-5 cells per experiment) are expressed as a 
percent change from the baseline FRET ratio (I535 nm/I480 nm, B and D). NOS inhibition (L-NAME) 
attenuated (P < 0.01) the effects of hypoxia on FRET.MT and cygnet-2 (B and D).    
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Figure 11.  Hypoxia regulates both FRET.MT and cygnet-2 function in isolated perfused 
mouse lung. Representative images from a single experiment using FRET.MT illustrate the 
separation of the two emitted signals (cyan and yellow) following spectral unmixing based on 
individual calibration spectra for each protein (A). The spectral reports from single experiments 
with each reporter (B and C) show decreases in energy transfer following hypoxia, as evidenced 
by an increase in the emission intensity of the donor (cyan, 480 nm) and a decrease in that of 
the acceptor (yellow, 535 nm). The mean change in energy transfer (I535/I480) for the FRET.MT 
reporter was -24.5 ± 5.4% (n=5), and -26.4 ± 5.7% (n=6) for cygnet-2 (D). 
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3.2.6 HPV attenuated in MT-/- mice.   
 
Blunting (P<0.05) of hypoxic 
induced increases in perfusion 
pressure was observed in the IPLs 
of MT-/- vs. MT+/+ mice (Figure 12, 
n=5).  This effect was specific for 
hypoxia in that U46619-mediated 
increase in perfusion pressure was 
similar in MT -/- mice (3.1 ± 0.8 
cmH2O) and MT+/+ (3.5 ± 0.8 
cmH2O).  
Figure 12.  Metallothionein (MT) null mice have a blunted HPV. P < 0.05 and n=5 per group. 
 
 
3.2.7 NO-related vasoconstriction in the isolated mouse lung. 
 
The potential vasodilatory limbs of NO-mediated effects on HPV were eliminated via 
inhibition of sGC (ODQ, 10 M) and NO-sensitive large conductance Ca2+-activated 
potassium channels (BKCa2+, charybdotoxin, ChTx, 0.1 M) in order to confirm that NO 
could act as a vasoconstricting agent in buffer-perfused, isolated mouse lungs (Figure 
13). In these experiments, hypoxia alone caused a 0.8 ± 0.4 cmH2O increase (P < 0.05) 
in perfusion pressure.  When DETAnonoate was added in the presence of ODQ and 
ChTx, the NO donor caused a further increase in pressure during hypoxia (n = 5, P < 
0.05). These effects were reversed by TPEN (25 M), suggesting that the 
vasoconstrictor effects of exogenous NO are mediated by changes in zinc. In separate 
sets of control experiments, ODQ alone caused a 2.4-fold increase in HPV (1.8 ± 3.6 vs. 
0.8 ± 2.8 cm H2O increase in perfusion pressure, P < 0.05), whereas ChTx alone had 
no effect either on baseline pressure or HPV. The addition of DETAnonoate (100 M) 
alone to the perfusate decreased HPV from 2.6 ± 0.8 cm H2O with hypoxia alone to 1.3 
± 0.4 cm H2O in the presence of the NO donor (Figure 14).   
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Figure 13. NO-mediated vasoconstriction in the isolated perfused lung (IPL). Eliminating 
the vasodilatory effects of NO on the hypoxic pressor response via pharmacological inhibition of 
sGC (ODQ) and NO-sensitive large conductance Ca2+-activated potassium channels (BKCa2+, 
charybdotoxin, ChTx) enhanced HPV (P < 0.01) in the mouse IPL. Under these conditions, the 
NO donor, DETAnonate caused further constriction (P < 0.05). a, different from hypoxia. b, 
different from hypoxia/ODQ/ChTx. c, different from hypoxia and hypoxia/ODQ/ChTx  (n=5).  
 
 
Figure 14. NO-mediated attenuation 
of hypoxic vasoconstriction in the 
isolated perfused rat lung.  In 
control experiments, the NO donor, 
DETAnonate (100 M) decreased the 
hypoxic pressor response from 2.6 ± 
0.8 to 1.3 ± 0.4cmH2O (P < 0.05, 
n=3).  
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3.3 DISCUSSION 
 
 
A combination of optical imaging modalities and fluorescent reporter molecules was 
used to visualize the NO-MT-zinc signaling pathway in both pulmonary endothelial cells 
and intra-acinar arteries of the isolated perfused mouse lung. Having confirmed that 
both intra-acinar pulmonary arteries (Figure 3) and isolated pulmonary endothelial cells 
(Figure 5) actively constricted in response to hypoxia,  it was shown that: i) hypoxia-
induced changes in zinc homeostasis that were critically dependent on NO synthesis 
and metallothionein in mouse lung endothelial cells (Figure 7)  and endothelium of the 
intact  mouse IPL (Figure 8); and ii) hypoxia-induced production of NO in both cultured 
endothelial cells and endothelium of the IPL as revealed by FRET reporters for S-
nitrosation of MT and activation of sGC (Figure 10 and Figure 11). Furthermore, 
following inhibition of the major NO-mediated effects on HPV (sGC and KCa2+ 
channels), the NO donor, DETAnonoate was shown to enhance the hypoxic pressor 
response in the isolated mouse lung and this effect was reversed by zinc chelation 
(Figure 13). Lastly, pharmacologic (TPEN, Figure 9) and genetic (targeted ablation of 
zinc regulatory protein, MT, Figure 12) inhibition of hypoxic mediated elevations in zinc 
significantly blunted HPV. Collectively, these data suggest that hypoxia-induced 
increases in NO synthesis contribute to hypoxic vasoconstriction via formation of S-
nitrosothiol in the metal binding center of MT and resultant changes in zinc 
homeostasis.  
 
3.3.1 HPV and nitric oxide production.   
 
While exhaled NO decreases in perfused lungs in response to alveolar hypoxia, the 
effects on perfusate NO-x levels appear to be both species and concentration 
dependent, requiring ≤1% inspired oxygen to reduce NO-x in isolated rabbit lungs 
109. In 
contrast, acute increases in pulmonary vascular resistance and HPV associated with 
pharmacological inhibition of NOS suggest that NO is generated during hypoxic 
exposure221. In vitro data is similarly conflicting with reports of decreased eNOS activity 
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in aortic endothelial cells241 but enhanced biosynthesis of NO in cultured pulmonary 
artery endothelial cells 242attributed to hypoxia-induced increases in calcium 243. The 
data suggest that NO production is increased in the mouse IPL during hypoxia as the 
FRET efficiency of both the cygnet-2 and FRET.MT reporter molecules234 was 
decreased in a NOS-dependent manner following exposure to low pO2. Previously it 
was noted that: 1) eNOS-derived NO, NO donors and NO gas, cause changes in 
FRET.MT 151 and increases in labile zinc 191; and 2) MT was the requisite target for NO 
resulting in the changes in zinc homeostasis191. It was also confirmed that FRET.MT 
was sensitive to DETAnonoate when expressed in the mouse IPL244.  
 
3.3.2 NO and acute HPV.  
 
Pharmacological inhibition of NO synthesis causes a 2-fold increase in HPV in the 
mouse IPL 167. Targeted disruption of individual NOS isoforms demonstrated that eNOS 
is the principal source of the NO modulating acute responses to hypoxia 163,167. Thus 
increases in NO would cause pulmonary vasodilatation, and attenuation of the hypoxic 
vasoconstrictor response, via stimulation of sGC and resultant increases in cGMP. 
Stable cGMP analogues decrease the strength of HPV and guanylate cyclase inhibition 
markedly amplifies the vasoconstrictor response to hypoxia in isolated rat lungs165. 
Therefore, dissecting a potential vasoconstrictor response of NO is pharmacologically 
challenging. Nonetheless, when the known vasodilatory limbs (sGC and BKCa2+) of NO-
mediated effects on HPV were inhibited, it was observed a small but significant increase 
in pulmonary arterial pressure in response to DETAnonoate.  Voelkel and colleagues 
245-246 described a paradoxical vasoconstrictive effect of normally vasodilatory stimuli, 
including NO and cGMP, in the pulmonary vasculature of hypoxic rat lungs that were 
perfused with red blood cell (RBC) lysate. Though the mechanisms mediating NO-
induced constriction remain uncertain, it appeared that second messenger function was 
altered by an undefined factor released during hemolysis. One possibility is that 
oxyhemoglobin (HbO2) from hemolyzed red blood cells acted to scavenge ∙NO thus 
limiting the activation of sGC.  However, HbO2 would not be expected to affect the NO-
related species (nitrosonium) destined to participate in the S-nitrosation of 
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metallothionein234. While the present data were obtained in non-recirculated, buffer 
perfused lungs, the possibility that there are trace amounts of hemolysate in the 
preparation that could affect the sGC pathway without altering NO-induced changes in 
labile zinc cannot be eliminated.  
 
3.3.3 S-nitrosation of MT in hypoxia.  
 
Protein S-nitrosation has been observed following stimulation of all NOS isoforms247. 
The favored in vitro reaction pathway for S-nitrosation involves NO and molecular 
oxygen to generate the nitrosonium donor N2O3 and therefore O2 is assumed to be 
necessary for NO-dependent protein S-nitrosation. However several mitochondrial 
proteins are nitrosated under anaerobic conditions and it is possible that the oxidative 
requirements of this chemistry can be fulfilled in vivo by electron sinks other than 
molecular oxygen 248.  Such issues highlight the importance of discerning between 
acute vs. chronic and anoxic vs. hypoxic effects on the signaling pathways of interest. 
Acute hypoxia has been associated with enhanced biosynthesis of NO in cultured 
pulmonary artery endothelial cells242  whereas 4-24 hrs of prolonged low oxygen 
decreases endothelial derived NO production by disrupting the microenvironment of 
eNOS and L-arginine transport 249.  S-nitrosation of MT requires the presence of 
oxygen250 and will not occur in anoxia251.  Indeed anoxia is associated with pulmonary 
vasodilation10. Accordingly, it is important to note that the gas mixtures in these studies 
were associated with pO2 measurements in the range of 10-15 mmHg for cell culture 
and 30-35 mmHg for IPL models. 
 
3.3.4 Mouse model of HPV. 
 
 In contrast to other species, HPV in mice is relatively low (1-3 cmH2O)
252. In addition, 
there are observed differences in hypoxic vascular reactivity between mouse strains 41. 
Regardless it is important to use genetically engineered animals to conclusively 
establish a role for MT in hypoxia-induced zinc release in the regulation of vascular 
tone. HPV was documented to be reproducible over two hours of repeated 10-15 min 
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hypoxic exposures (15 min recovery) and was increased by inhibition of both NOS (L-
NAME) and sGC (ODQ) as shown in other animal models. Similar to the mouse data, 
zinc chelation (TPEN) reversibly blunted HPV in the IPL of rats.  Although the hypoxic 
pressor responses in both the mouse and rat were modest, the effects of TPEN were 
apparent and reversible in the two species suggesting that the modulating influence of 
hypoxia-induced zinc release on the HPV is of physiological relevance. 
 
3.3.5 Summary.   
 
Although the precise mechanism underlying HPV remains unclear, current dogma 
suggests that unique intrinsic properties of pulmonary vascular smooth muscle (oxygen 
sensing and coordination of ionic conductances leading to constriction) that are 
modulated by communication with endothelium (biosynthesis of vasoactive substances 
including NO) account for hypoxic mediated vasoconstriction of pulmonary arteries.  
Nonetheless, previous studies using computer enhanced videomicroscopy49 or X-ray 
microfocal angiographic images113 in perfused dog lungs and these studies using 
scanning laser confocal microscopy of  intra-acinar pulmonary arteries of genetically 
modified mice, reveal an important contribution of these small vessels (≤40 m 
diameter) in HPV.  Since this anatomic site is composed primarily of endothelial cells 
with solitary or discontinuous smooth muscle like cells (e.g. pericytes) in their wall, the 
nature of contractile events within the microcirculation are likely to be distinct from 
vasoregulation of proximal pulmonary vessels. Pericytes have been shown to induce 
constriction by contraction of cell processes which partially envelop the capillary and 
could potentially contribute to the observed hypoxia-induced constriction of small 
pulmonary vessels.  However, indirect evidence using vasoactive chemicals to induce 
reorganization of the endothelial microfilament system also suggests that endothelial 
cells play a role in capillary constriction in a number of vascular beds 253. While the data 
shown indicates that isolated pulmonary (but not aortic) endothelial cells actively 
contract in response to hypoxia, the integrated subunit of intra-acinar arteries under 
investigation contains both endothelium and a small component of discontinuous 
smooth muscle and as such either or both cell types could contribute to vasomotor tone.   
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  It is now apparent that: a) S-nitrosation of zinc sulfur clusters is an important 
component of NO signaling; and b) MT is a critical link between NO and intracellular 
zinc homeostasis191. The present data support the contention that zinc thiolate signaling 
is a component of acute hypoxia mediated NO biosynthesis and that this pathway may 
contribute to hypoxic induced vasoconstriction within the pulmonary microcirculation.  
Although the precise mechanism by which increased labile zinc may cause 
vasoconstriction remains unclear, it is noteworthy that zinc associated proteins account 
for a large part of mammalian proteome and many of these candidate targets are 
components of signaling and effector pathways in cellular contraction. For example, the 
zinc sensitive protein kinase C isoform, PKC epsilon, is activated in response to hypoxia 
and has been shown to play a pivotal role in mediating acute hypoxic vasoconstriction in 
mice254.  
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4 A ROLE FOR ZINC IN REGULATING HYPOXIA-INDUCED CONTRACTILE 
EVENTS IN PULMONARY ENDOTHELIUM 
 
 
 
4.1 INTRODUCTION 
 
Hypoxic pulmonary vasoconstriction (HPV) is a complex, multifactorial phenomenon 
resulting in shunting of blood from areas of poor gas exchange to better ventilated 
regions of the lung 238. Previous data showed that acute hypoxia-induced increases in 
nitric oxide (NO) biosynthesis result in increases in intracellular free zinc that in turn 
contribute to vasoconstriction of small, intra-acinar arteries of lung255. As this anatomic 
site is composed primarily of endothelial cells with only solitary or discontinuous smooth 
muscle-like cells (e.g., pericytes) in their wall256, the potential for hypoxia-zinc-mediated 
contraction in pulmonary endothelium was investigated.  It was then confirmed that 
isolated pulmonary (but not systemic) endothelial cells constricted in hypoxia255 and that 
these contractile events were associated with hypoxia-induced increases in labile zinc. 
The mechanism by which zinc can induce vasoconstriction in the pulmonary vasculature 
is not known. However, zinc-associated proteins account for roughly 10% of the human 
proteome and many of these putative targets for hypoxia-released zinc are involved in 
signaling pathways regulating cellular contractility.  
Endothelial cells contain all the molecular machinery required to generate contractile 
force via the actomyosin motor. Contraction is initiated by phosphorylation of the 20 kDa 
regulatory myosin light chain (MLC) at S19/T18122.  The phosphorylation of MLC is 
dependent upon a balance between the activities of calcium/calmodulin dependent MLC 
kinase (MLCK) and myosin light chain phosphatase (MLCP).  Remodeling of the 
endothelial actin cytoskeletal in response to either hypoxia, or the pro-coagulant protein, 
thrombin, involves Rho/ROCK, MLC and actin-related proteins257. One potential 
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connection between these signaling pathways and zinc is the relationship between 
divalent metal ions and sulfhydryl residues in the activation of type 1 and type 2A 
serine/threonine phosphoprotein phosphatases (PPases), with zinc having been shown 
to be a potent inhibitor of lambda-PPase 226.  A further link is provided by the indirect 
evidence supporting a role for zinc in strengthening of focal adhesions 258, though the 
mechanism(s) underlying this phenomenon are not clear. Likely participants in 
endothelial contractile pathways also include PKC isoforms that are known to be tightly 
regulated by zinc259 and participate in HPV254 (i.e. PKC ). 
The present studies were designed to investigate the mechanisms by which 
hypoxia-released zinc induces contraction in pulmonary endothelium and delineate the 
signaling pathways involved in zinc-mediated changes in the actin cytoskeleton, as the 
data indicates hypoxia-induced alterations in zinc homeostasis promote endothelial cell 
contraction via changes in the phosphorylation status of MLC and increased 
formation/stabilization of actin stress fibers.  
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4.2 RESULTS 
 
4.2.1 Hypoxia induces zinc-dependent changes in the actin cytoskeleton of isolated 
pulmonary microvascular endothelial cells.  
 
It was previously reported that hypoxia induced increases in labile zinc in small 
intraacinar arteries of the isolated perfused mouse lung255.  The observation that 
hypoxic vasoconstriction was blunted in the lungs of mice in which the major zinc 
binding protein (metallothionein) was knocked-out (MT-/- mice), or in wild-type mice 
perfused with the zinc chelator TPEN, led to the hypothesis that increases in 
intracellular zinc contribute to constriction in the pulmonary microvasculature. The 
anatomic site in question was shown to be composed primarily of endothelial cells255 
and these initial investigations confirmed the potential for hypoxia-zinc-mediated 
contraction in isolated primary cultures of pulmonary endothelium.  In the present report, 
the zinc dependency of hypoxia-induced changes in the actin cytoskeleton was first 
assessed in isolated rat pulmonary microvascular endothelial cells (RPMVEC).  Hypoxic 
exposure (30 mins) increased the abundance or total volume of actin per cell, as well as 
the alignment of actin stress fibers (Figure 15 mean data Figure 16B) compared to 
normoxia.  Treatment with the zinc chelator, TPEN (25µM) reduced the effects of 
hypoxia on the actin cytoskeleton (Figure 15 and Figure 16B), suggesting that hypoxia-
induced changes in intracellular zinc contribute to the formation or stabilization of actin 
stress filaments in RPMVEC. While early reports suggest that zinc can alter skeletal 
muscle contractility224, little is known about the effects of zinc on the intracellular 
contractile apparatus in either muscle or non-muscle cells. Data from fixed pulmonary 
endothelial cells showed that exogenous zinc (in the presence of the zinc ionophore, 
pyrithione) also increased the abundance and altered the distribution of actin stress 
fibers (Figure 16), consistent with a contractile phenotype.     
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Figure 15.  Hypoxia induces zinc-dependent changes in the actin cytoskeleton of isolated 
rat pulmonary microvascular endothelial cells (RPMVEC). The left hand panel shows Alexa 
647-phalloidin staining of filamentous actin (red) and immunostaining for paxillin to reveal focal 
adhesions (green). Each image is projected 3D reconstruction of the cells. The right hand panel 
shows the volume rendered (Imaris software, Bitplane, Saint Paul, MN) image of actin 
abundance (white).  Hypoxic exposure (30 mins) increased both the total volume of actin per 
cell (mean data shown in Figure 16B), as well as the alignment of actin stress fibers compared 
to normoxia (baseline).  Treatment with the zinc chelator, TPEN (25µM) or the Rho kinase 
inhibitor, Y27632 (10 M) reduced the effects of hypoxia on the actin cytoskeleton.  
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Figure 16. Exogenous zinc increases actin stress fibers in isolated pulmonary 
microvascular endothelial cells. The left hand panel shows Alexa 647-phalloidin staining of 
filamentous actin (red) and immunostaining for paxillin to reveal focal adhesions (green). Each 
image is projected 3D reconstruction of the cells. The right hand panel shows the volume 
rendered (Imaris software) image of actin abundance (white).  Exogenous zinc (30 mins, 10 M 
in the presence of 2 M pyrithione) increased both the total volume of actin per cell (mean data 
shown in Figure 16C), as well as the alignment of actin stress fibers compared to baseline.  
Treatment with the myosin light chain kinase inhibitor, ML-7 had little effect on zinc-induced 
stress fiber formation, whereas the Rho kinase inhibitor, Y27632 (10 M) reduced the effects of 
hypoxia on the actin cytoskeleton.  
 
Total internal reflectance fluorescence (TIRF) microscopy of enhanced green 
fluorescent protein (EGFP) tagged actin was used to examine hypoxia and zinc induced 
contractile events in live cultures of RPMVEC. TIRF relies on an evanescent wave 
generated perpendicular to the optical axis when light reflects off of a surface at an 
incident angle. The intensity of the evanescent wave decays exponentially and 
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effectively penetrates only 100–150 nm beyond the coverslip into the cell 12, thereby 
confining the excitation of fluorophores to an extremely thin axial slice.  As a result the 
signal to noise ratio in TIRF is extremely high. While the approach will only image 
events at the basal surface of the cell, one can be certain that emitted signal is only 
derived from this region of the cell, as opposed to other methods which are not 
specifically constrained in the Z-axis to a single plane (e.g. confocal).  Using TIRF 
hypoxia was shown to result in time-dependent and reversible (Figure 18) increases in 
the abundance and alignment of basal stress fibers (Figure 18 and Figure 19). 
Consistent with the data in fixed cells (Figure 15), the addition of the zinc chelator, 
TPEN, during hypoxia, resulted in the rapid disassembly of actin stress filaments 
(Figure 19).  
When cells were plated on rigid surfaces, such as fibronectin covered coverslips 
in Figure 15 to Figure 19 (instead of pliable matrices, such as the collagen embedded 
cells depicted in Figure 5 and Figure 6); there is generation of isometric tension, as the 
actin-myosin motor cannot actually decrease the length of fibers117.   This, results in 
greater thickness of stress fibers and clumping of focal adhesion proteins associated 
with membrane attachment to the extracellular matrix. These focal adhesion proteins 
(e.g. paxillin) are present at the end of stress fibers and promote linkage of the 
cytoskeleton to the extracellular matrix, and allow actin-myosin interactions to result in 
traction forces associated with the maintenance and remodeling of cellular shape117.  
Hypoxia has been shown to induce paxillin phosphorylation and activation260, and 
changes in paxillin distribution have been reported to associate with FAK and Rho 
signaling103,261 Peripheral distribution and clustering of focal adhesions is usually 
associated with Rho signaling pathways262, although, it may also occur independently of 
Rho261.  Confocal images revealed that both hypoxia and zinc exposure resulted in a 
decrease in the number of focal adhesions (6% and 21% respectively).  In addition, 
there were increases in the percentage of focal adhesions in the periphery in response 
to exogenous zinc.  Hypoxia and zinc also promoted a marked increase in the average 
area of focal adhesion, indicating aggregation of paxillin into larger cluster.  Such 
changes in focal adhesions have been proposed to couple with actin force 
generation263.    
A 
 63 
A
V
E
R
A
G
E
 S
IZ
E
 O
F
 
 F
O
C
A
L
 A
D
H
E
S
IO
N
 
B C D 
N
O
R
H
YP
O
ZI
N
C
0
2
4
6
A
v
e
ra
g
e
 f
o
c
a
l 
a
d
h
e
s
io
n
 s
iz
e
 (
m
2
)
N
O
R
H
YP
O
ZI
N
C
0
50
100
150
200
T
o
ta
l 
o
f 
fo
c
a
l 
a
d
h
e
s
io
n
s
 p
e
r 
c
e
ll
N
O
R
H
YP
O
ZI
N
C
0
20
40
60
80
100
P
e
rc
e
n
ta
g
e
 o
f
fo
c
a
l 
a
d
h
e
s
io
n
s
 a
t 
p
e
ri
p
h
e
ry
* 
* 
* 
* 
  
 
 
 
 
 
Figure 17.  Hypoxia and zinc promote size and distribution changes focal adhesions. (A) 
Confocal micrographs of labeled actin (red) and paxillin (green) shows the changes in amount, 
morphology and distribution.  (B) Decrease in the average number of focal adhesions in 
response to hypoxia or zinc.  (C)  Percentage of focal adhesions present in the periphery. (D) 
Changes in the average area of focal adhesions. Bar 25µm (* indicates significant differences to 
normoxic conditions,  p<0.05). 
 
 
4.2.2 Hypoxia and zinc induce MLCK-independent phosphorylation of MLC.  
 
Similar to the contraction of smooth muscle, changes in contractile force in endothelial 
cells are accomplished via the regulation of the level of phosphorylation of the 
regulatory myosin light chain (MLC)264. In conjunction with  the observed hypoxia-
induced augmentation of actin stress fibers (Figure 15-Figure 19), Western blotting 
revealed increases in both mono (2.7 ± 0.8 fold) and di-phosphorylated (2.5 ± 0.4 fold) 
MLC (Figure 20A), that were reduced in the presence of the zinc chelator, TPEN (to 1.6 
± 0.2 and 1.8 ± 0.1, respectively). TPEN alone had no effect on phosphorylation of MLC 
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(0.8 ± 0.1 and 1.0 ± 0.1 fold changes over control, for mono- and di-phosphorylated 
MLC, respectively). Addition of exogenous zinc (10 M + 2 M pyrithione) also resulted 
in small but significant increases in MLC phosphorylation (1.3 ± 0.2 fold and 1.6 ± 0.5 
fold increases for mono and di-phosphorylated MLC, respectively), supporting a role for 
zinc in modulating endothelial contractility. The MLCK-specific inhibitor ML-7 265, which 
competes with ATP binding to the active sites on MLCK, had no effect on zinc-induced 
changes in stress fiber formation (Figure 16C) or MLC phosphorylation (1.23 ± 0.2 and 
1.4 ± 0.3 fold changes, relative to baseline, Figure 20A), suggesting that MLCK is not a 
downstream target for zinc in promoting increased actomyosin interactions. ML-7 alone 
had no effect on the phosphorylation of MLC (0.9 ± 0.1 and 0.8 ± 0.2 fold change over 
baseline for mono- and di-phosphorylated MLC, respectively).   
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Figure 18. TIRF microscopy of EGFP-actin reveals acute hypoxia induced time dependent 
changes in the actin cytoskeleton. With TIRF, the excitation of fluorophores is confined to the 
region 100–150 nm beyond the surface of the coverslip. Thus only events that occur at the 
basal surface of the cell were visualized. Panels A-E show the changes in basal stress fibers 
that occur in response to hypoxia (exposure was initiated after the baseline image taken in 
panel A). The cells were returned to normoxia at 40 minutes (following collection of the image 
shown in Panel E) with Panels F-I showing the disassembly of stress fibers during the recovery 
period. 
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Figure 19. TIRF microscopy of EGFP-actin reveals that hypoxia induced changes in the 
actin cytoskeleton are reversed by zinc chelation. Panels A-E show the response to a 40 
minute period of hypoxia (instituted after the collection of the baseline image shown in Panel A). 
The addition of the zinc chelator, TPEN, during hypoxia (following collection of the image shown 
in Panel E) resulted in a time dependent disassembly of hypoxia-induced basal stress fibers 
(Panels F-H).  
 67 
 
 
Figure 20.   Hypoxia 
induced changes in zinc 
homeostasis modulate 
myosin light chain (MLC) 
phosphorylation in isolated 
rat pulmonary 
microvascular endothelial 
cells. Panel A shows a 
representative Western blot 
for di-phosphorylated MLC 
(S19/T18) and mean data for 
mono-phosphorylated (S19), 
and di-phosphorylated MLC 
are pictured.  Phosphorylated 
protein is expressed relative 
to total protein level (n = 3 to 
5 separate experiments). 
Panel B shows representative 
Western blots and mean data 
for phosphorylated MYPT1 
(T853, n = 3).  Panel C shows 
the hypoxia-induced 
phosphorylation of CPI-17 
(T38) and its suppression by 
either TPEN or  PKC 
inhibition (Ro-31-8220, n= 2). 
All inihitors were present for 
the duration of the hypoxic or 
zinc exposure (30 mins).  
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4.2.3 Hypoxia induced changes in MLC phosphatase (MLCP) activity are modulated by 
altered zinc homeostasis.  
 
The Rho family of small GTPases plays a key role in regulating the endothelial 
contractile apparatus through inhibition of MLCP activity266. Rho kinase (ROCK) 
signaling in smooth muscle has been shown to be critical to sustaining chronic HPV72; 
and hypoxia-induced Rho/ROCK activation is associated with increased cell stiffness in 
isolated pulmonary microvascular endothelial cells118. Consistent with these reports, it 
was found that hypoxia-mediated changes in the actin cytoskeleton (Figure 15), as well 
as hypoxia-induced increases in mono- and di-phosphorylated MLC (Figure 20A) were 
dramatically reduced in pulmonary endothelial cells in the presence of the Rho kinase 
inhibitor, Y-27632 (10 M). Furthermore, Y-27632 virtually abolished zinc-mediated 
increases in basal stress fiber formation (Figure 16A and B) and significantly decreased 
the zinc-induced phosphorylation of MLC (Figure 20A).  
MLCP activity requires binding of the regulatory domain, MYPT1, to the catalytic 
domain (PP1c) as well as the substrate (myosin).  Phosphorylation of MYPT1 reduces 
its binding affinity for myosin, inhibiting the activity of the holoenzyme 91,267.  Western 
blot analysis showed increases in phospho-MYPT1 (Thr853) in response to either 
hypoxia or exogenous zinc (1.4 ± 0.2 and 1.7 ± 0.1 fold, respectively; Figure 20B).  
Exposure of RPMVECs to hypoxia or zinc in the presence of the Rho kinase inhibitor, Y-
27632 (10 M) resulted in a decrease in MYPT1 phosphorylation at Thr853 (Figure 
20B) further supporting the involvement of Rho/ROCK signaling in promoting stress 
fiber formation in response to zinc. Whereas hypoxia-induced MLC phosphorylation was 
shown to be sensitive to zinc chelation, TPEN had no effect on the phosphorylation of 
MYPT1 in response to hypoxia suggesting that the inhibitory effects of hypoxia-released 
zinc on phosphatase function (and thus the phosphorylation status of MLC) could be 
mediated by zinc-related signaling that targets the catalytic subunit (PP1c) of the 
enzyme.    
Independently of Rho/ROCK mediated changes in cell contractility, PKC 
signaling pathways also regulate the organization of cytoskeletal proteins through the 
inhibition of MLC phosphatase and resulting increases in MLC phosphorylation264. 
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Furthermore, zinc-induced changes in endothelial cell contractility, intracellular zinc 
concentrations have been reported to influence PKC activity and processing 259,268-269.  
Accordingly, it was found that zinc-induced phosphorylation of MLC was suppressed by 
PKC inhibition with Ro-31-8220 (Figure 20A), suggesting that PKC-related signaling can 
transduce the effects of zinc on pulmonary endothelial cell contraction. Unlike the 
inhibition of MLCP by Rho/ROCK, PKC-mediated phosphatase inhibition acts through 
phosphorylation of the PKC substrate, CPI-17 (PKC-potentiated inhibitory protein of 17 
kDa) rather than phosphorylation of MYPT1270, explaining why Ro-31-8220 had no 
effect on MYPT1 phosphorylation (Figure 20B). Phosphorylation of CPI-17 at T38 
promotes inhibition of the catalytic subunit of PP1 and the activity of the MLCP 
holoenzyme270. Hypoxia-induced phosphorylation of CPI-17 (T38) was shown to be 
suppressed by TPEN and PKC inhibition (Ro-31-8220, Figure 20C) reduced the zinc-
mediated phosphorylation of the protein. Collectively these data indicate that hypoxia-
released zinc contributes to changes in the actin cytoskeleton and contraction of 
pulmonary endothelium through activation of the PKC-CPI-17 signaling pathway and 
inhibition of MCLP. 
 
4.2.4 Zinc-induced activation of PKCε modulates hypoxia induced contraction of 
pulmonary endothelium.  
 
PKC activators, including mimetics of the natural ligand diacyglycerol (i.e. phorbol 
myristae acetate (PMA)), stimulate contraction, and potentiate HPV; whereas PKC 
inhibitors decrease HPV271.  While the roles of individual isoforms of PKC in the control 
of pulmonary vascular reactivity have not been clearly defined, wide-body deletion of 
PKC  was shown to blunt murine HPV leaving ANGII and KCl responses preserved 254. 
It can be postulated then, that PKC , a zinc sensitive signaling molecule in HPV254 may 
transduce hypoxia mediated changes in zinc homeostasis. To test this hypothesis, 
hypoxia-dependent contractile behavior at the level of the single cell was first examined 
using high resolution differential interference contract (DIC) imaging of changes in cell 
surface area in RPMVEC and sheep pulmonary artery endothelial cells (SPAEC). A role 
for PKC in mediating hypoxia-induced endothelial cell contraction was initially 
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investigated using Ro-31-8220, which inhibits PKCε with an IC50 of 0.024 µM 
272. Figure 
21A shows a representative field of cells at baseline (A, D); during hypoxia (at 30 min, 
B, E); and following the recovery period (30 min, C, F). Hypoxia induced decreases in 
surface area were attenuated in the presence of Ro 31-8220 (from 16 ± 3.1% to 4.5 ± 
2.6% with Ro-31-8220, P < 0.005, Figure 21C). A dominant negative approach was 
adopted to study the role of PKC , specifically, in modulating hypoxia-induced 
endothelial cell contraction. The infection efficiency was extremely low in RPMVEC, and 
thus, for these studies, they were replaced with SPAEC which have been shown to: 1) 
increase NO production when exposed to acute hypoxia 255; 2) increase intracellular 
labile zinc in response to NO 191,234; and 3) contract in response to hypoxic exposure.  
SPAEC were infected with an EGFP-tagged herpes simplex virus encoding dominant 
negative PKC  24 hrs prior to hypoxic exposure. Hypoxia-induced contractile responses 
were compared between cells expressing the dominant negative PKCε construct 
(Figure 21B, green) with uninfected cells within the same experiment. The 17.0 ± 2.5% 
decrease in area in the uninfected cells was significantly greater than the contraction 
observed in cells expressing PKC DN (0.2 ± 1.5%, P = 0.012, Figure 21D). These data 
suggest that PKC serves as one effector molecule mediating hypoxia-induced 
constriction in the pulmonary microvasculature.  
PKC enzyme activity is associated with the physical translocation of the enzyme 
from the cytosol to the cell membrane 273-274.  Using cell fractionation followed by 
Western blot analysis a time-dependent decrease in PKCε protein levels in the cytosolic 
fraction (P<0.05, Figure 22A and C) and a corresponding increase in the appearance of 
the protein in the membrane fraction (P<0.05, Figure 22B and D) was observed when 
primary cultures of pulmonary endothelial cells were exposed to acute hypoxia. These 
hypoxia induced effects were reversed by addition of the zinc specific chelator TPEN 
(10 M, P<0.001). Similar changes in PKCε localization were achieved by addition of 
exogenous zinc to the media during normoxia (Figure 22E, F and G, P < 0.05). 
Furthermore, exogenous zinc (10 M) also caused increases (P < 0.05) in PKCε 
enzyme activity that were reversed by addition of TPEN (10 M, Figure 23A). Lastly, 
hypoxia induced time-dependent increases in PKCε enzyme activity (Figure 23B) that 
were reversed by the addition of the NOS inhibitor, L-NAME (1mM, P < 0.05), or the 
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zinc specific chelator TPEN (10 µM, P < 0.001) confirming that the effects of hypoxic 
exposure on PKC  enzyme function in isolated pulmonary endothelial cells are 
regulated by NO-mediated changes in zinc homeostasis. 
 
 72 
Figure 21.  Zinc-induced activation of PKCε contributes to 
hypoxia induced contraction of pulmonary endothelium. 
Panel A represents the effects of PKC inhibition with Ro-31-8220 
on isolated pulmonary microvascular endothelial cells. The 
images show the same representative field of cells at baseline 
(A, D), during hypoxia (30 min, B, E) and following the recovery 
period (30 min, C, F). The hypoxia-induced contraction shown in 
A-C was significantly attenuated in the presence of Ro-31-8220 
(1 M, D-F). The mean data for 6 separate experiments (with 3-5 
cells per experiment) is shown in the bar chart (Panel C, 
P<0.05). Panel B represents the effects of dominant negative 
PKC  on hypoxia induced contraction.  The images show a 
representative field of cells at baseline, during hypoxia (at 30 min) and following the normoxic 
recovery period (30 min). The contractile responses of cells expressing the GFP-tagged 
PKC DN construct (green) were compared to cells that were not infected.  In the example 
shown, the uninfected cell (cell 1) shows 10% decrease in area as compared to cells expressing 
PKC DN (cells 2 and 3). The mean data for 4 separate experiments (with 2-6 cells per group 
per experiment) shown in the bar chart in panel D (P< 0.05). 
A 
B C D 
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Figure 22. Hypoxia and zinc induce translocation of PKCε in isolated pulmonary 
endothelial cells.  Western blot analysis against PKCε revealed a loss of protein in the 
cytoplasm and an increase in the membrane fraction following hypoxia (Panels A-D). These 
changes were reversed by the addition of 10 M TPEN. Treatment with exogenous zinc also 
resulted in a significant loss of PKCε in the cytoplasm and accumulation in the membrane 
fraction (Panels E-G) that was reversed by TPEN (10 µM). Protein levels were normalized to β-
actin (n = 3, * P < 0.05, ** P < 0.001). 
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Figure 23. Hypoxia induced increases PKCε activity are dependent on NOS and zinc. 
Zinc-induced increases in PKCε activity (Panel A) were reversed by TPEN (10 µM, n=3, 
P<0.05). Hypoxia induced increases in enzyme activity (Panel B) were reversed by the 
competitive NOS inhibitor L-NAME (1 mM) or the zinc-specific chelator, TPEN (10 µM, n = 3, 
P<0.05).   
 75 
 
 
 
4.3 DISCUSSION 
 
The process of endothelial cell contraction requires the formation of contractile actin 
stress fibers containing bipolar arrays of myosin II between consecutive alpha-actinin 
foci90.  Interactions between actin and myosin are dependent on the phosphorylation 
state of myosin light chain (MLC), which in turn is determined by the balance between 
myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) 
activities.  While in vitro evidence supports activation of MLCK by zinc, it is not known 
whether this is a direct effect on the protein 228; nor is it known whether this activation 
contributes to force generation in vivo. Hypoxia has been shown to induce cytoskeletal 
changes in isolated pulmonary microvascular endothelial cells independent of MLCK 
activation 118.  In accordance with these findings, zinc was found to also be capable of 
promoting stress fiber formation when MLCK is inhibited by ML-7 (Figure 16 and Figure 
20), suggesting that zinc acts through inhibition of MLCP in promoting cell contractility.   
 In vitro data show that zinc can interact directly with the catalytic core of MLCP 
(PP1c) and cause conformational changes that promote destabilization of the 
holoenzyme226.  It was observed that zinc chelation (TPEN) decreased hypoxia-induced 
MLC phosphorylation (Figure 20A) and caused disassembly of actin stress fibers during 
hypoxia (Figure 16 and Figure 19), but had no impact on phosphorylation of the 
regulatory subunit, MYPT1, of MLCP (Figure 20B). These data imply that hypoxia 
released zinc signals through the PP1 subunit of MLCP to affect changes in enzyme 
activity and cell contractility.    
 Inhibition of Rho kinase had a marked effect on the phosphorylation of MYPT1, 
as well as in stress fiber formation and distribution during hypoxic or zinc stimulation.   
While the Rho-associated binding protein kinase 1 (ROCK1) contains a conserved, 
cysteine-rich zinc binding region in the C1 domain93, the relationship between zinc and 
the Rho/ROCK pathway has not been investigated in the context of cellular contractility.  
In addition, Rho has been proposed to regulate actin polymerization through  activation 
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of Diaphanous related formin mDia, which accelerates nucleation and elongation of 
filaments275.  It has been proposed that mDia promotes the formation of thin filaments 
that are organized into thick stress fibers through ROCK derived pathways276.  This 
protein is also associated with microtubule stabilization by decreased tubulin subunit 
exchange at plus ends277.  Immunofluorescence analysis didn’t show any changes in 
microtubule structure in response to zinc (Figure 24), suggesting that alternative derived 
signaling pathways may be responsible for stress fiber formation and tension 
generation. Further studies are needed to determine if zinc may stimulate Rho derived 
signaling pathways 
  
Figure 24.  Zinc does 
not promote changes in 
microtule’s distribution.  
Immunofluorescence 
analysis of tubulin of rat 
pulmonary microvascular 
endothelial cells exposed 
to normoxic conditions or 
exogenous zinc (10 M in 
the presence of 2 M 
pyrithione) for 30 mins. 
 
 
Intracellular zinc concentrations influence PKC activity and processing in a 
number of cell types 259,268-269. It was recently observed that zinc contributed to tBH-
induced necrosis, in part, via a PKC-dependent pathway, providing one potential link 
between zinc and PKC in pulmonary endothelium 278-279. The diacylglycerol (DAG)-
binding sites of PKC have been mapped to two pairs of Zn fingers in the regulatory 
domain. Each finger contains six cysteines that fold to form a structure that coordinates 
2 Zn atoms 280-281. While oxidative stress is thought to activate PKC by modifying zinc 
thiolate clusters of the regulatory domain of the NH2 terminus,
 relieving autoinhibition 
and facilitating cofactor independent PKC activation 280, it has been suggested that 
changes in intracellular zinc affect PKC activity by targeting the enzyme’s C1 domain 
which contains cysteine rich finger like motifs that bind zinc 268.  The data indicates that 
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inhibition of PKC by Ro-31-8220 attenuated hypoxia induced contraction of isolated 
pulmonary endothelial cells (Figure 21), and that zinc-induced phosphorylation of the 
contractile regulatory protein, MLC was PKC-dependent (Figure 20). In addition, 
hypoxia-released zinc was shown to promote the phosphorylation of the PKC substrate, 
CPI-17 (Figure 20C). PKC acts through CPI-17 to stabilize the phosphorylation of MLC 
by inactivating MLC phosphatase, ultimately inducing stress fiber formation and cell 
contraction.  Such signaling has been shown to regulate the reorganization of 
cytoskeletal proteins and affect changes in barrier function in pulmonary endothelium 
236.  While there is compelling evidence supporting a critical role for zinc in maintaining 
epithelial barrier function in the context of inflammatory stress282 and it is not 
unreasonable to propose that zinc may also play a role in regulating endothelial barrier 
function, further studies are required to determine the downstream effects of the 
hypoxia/zinc pathway on endothelial permeability in the lung.   
Investigating a role for individual PKC isoforms in the described zinc signaling 
pathways regulating endothelial contractility is complicated by the lack of specificity of 
the pharmacological inhibitors and activators of the enzyme.  Ro-31-8220 has an IC50 of 
0.024 µM for PKC  272, however at high concentrations it can also inhibit PKC PKC II 
and PKC . The difficulties in using such inhibitors are further demonstrated by 
observations that Ro-31-8220 can activate c-Jun expression and inhibit mitogen-
activated protein kinase (MAP kinase) phosphatase-1 expression 283-284 . While the 
possibility that multiple isoforms of PKC play a role in modulating the response to 
hypoxia observed in pulmonary endothelium cannot be eliminated, the observation that 
the dominant negative approach to specifically inhibit PKC  also significantly attenuated 
the hypoxia-induced contraction of isolated cells confirmed the importance of the PKC  
isoform in mediating pulmonary endothelial cell contraction. Similarly, while zinc induced 
changes in MLC phosphorylation were abrogated by pharmacological inhibition of Rho 
kinase, it has been reported that Y-27632 can exert nonspecific inhibitory effects on 
PKC-mediated vascular responses at concentrations in excess of 10 M285 . Therefore, 
future studies incorporating specific knockdown of the genes in question are required to 
delineate the precise pathways regulating these events. 
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The specificity of the proposed zinc pathways in mediating hypoxia induced 
contraction in the pulmonary vasculature is not known. Both hypoxia-induced changes 
in labile zinc and hypoxia-induced endothelial cell contraction, as previously 
indicated255, were unique to cells derived from lung in that aortic endothelium did not 
exhibit these responses to low PO2. However, it was not anticipated that the tissue 
specificity of HPV is conferred by activation of PKC  in that PKC has been shown to be 
an important signaling molecule mediating contractile responses in both the systemic 
and pulmonary circulation286-287. Hypoxia induced changes in PKC  activity both L-
NAME and TPEN sensitive, arguing for a role for NO-induced changes in labile zinc in 
mediating enzyme function.  NO donors have also been shown to induce activation, 
translocation, and nitration of PKCε in cardiac myocytes278. In fact, both eNOS and 
iNOS proteins are associated with PKC  in the heart 273, though data obtained in PKC  -
/- mice suggested a  role for PKC  in the regulation of eNOS expression during chronic 
hypoxic exposure rather than the direct regulation of enzymatic activity 254. The 
collected data suggest a role for PKC in mediating the downstream effects of hypoxia-
induced changes in NO synthesis and intracellular zinc homeostasis to produce 
contraction of pulmonary endothelium. While data obtained using dominant negative 
approaches, and isoform specific antibodies, directly implicated the involvement of 
PKC , although the possibility that other pathways, or other isoforms of PKC, also 
contributing to HPV and/or the generation of contractile force in isolated pulmonary 
endothelial cells cannot be eliminated.  
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5 CONCLUDING REMARKS 
 
Contrary to what happens in the systemic vasculature, low oxygen levels in the lung 
promote vasoconstriction rather than vasodilatation. This phenomenon termed hypoxic 
pulmonary vasoconstriction (HPV), is thought to maintain efficient oxygenation by 
diverting blood flow away from poorly ventilated regions of the lung72. HPV is mediated 
locally by the coordinated effort of both smooth muscle cells and the endothelium.  The 
central event in the response of vascular smooth muscle cells to hypoxia is an increase 
in cytosolic calcium, which promotes actin-myosin interactions and cellular contraction.  
On the other hand, the role of endothelium has been proposed to be mostly modulatory, 
acting though the synthesis of vasoactive mediators including: nitric oxide (NO), 
prostacyclin and endothelin-180.    
 Laser scanning confocal microscopy (LSCM) allowed the examination of 
diameter changes of small intraacinar arteries of the isolated perfused mouse lung (IPL) 
and observed an active contraction to hypoxia, in small (<50µM in diameter) resistance 
vessels that lacked a continuous layer of smooth muscle.  The changes in vessel 
diameter were found to be dependent on eNOS derived NO and were associated with 
changes in intracellular labile zinc.  In addition, it was demonstrated that isolated rat 
pulmonary microvascular endothelial cells (RPMVECs) contracted in response to 
hypoxia, also in a NO and zinc dependent manner.  These data suggested an active 
contribution by the endothelium to HPV under the direction of a novel second 
messenger, zinc.  Further evidence is provided that hypoxia-induced alterations in zinc 
homeostasis promoted endothelial cell contraction via alterations in the phosphorylation 
state of the regulatory myosin light chain (MLC) and increased formation/stabilization of 
actin stress fibers.   
Various studies have reported that the synthesis of the vasodilator NO is limited 
during HPV and that its lack of production compared to baseline conditions may actually 
underline the phenomenon109.   This would be in agreement with the fact that NOS 
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requires oxygen for the synthesis of NO.  Later studies found conflicting evidence on the 
matter.  However, pharmacological inhibition of NOS or targeted disruption of eNOS 
augments HPV, suggesting that increases in NO synthesis during hypoxia attenuate 
vasoconstriction in the lung163-164,288.  In addition, there are studies indicating that NO 
survives longer in hypoxia in perivascular cells, potentially increasing NO bioavailability 
in the vascular wall289-290.  Vessel diameter also appears to play a role, since NO 
synthesis is potentiated at the level of small resistance pulmonary arteries where 
increases in shear stress are greatest80.  Hypoxia-induced increases in NO synthesis 
were confirmed using fluorescence resonance energy transfer (FRET) reporters that 
detect nitrosyl-heme-Fe (associated with increases in cGMP production by sGC) and S-
nitrosation of metallothionein (MT), both in isolated endothelial cells and in the mouse 
IPL.  
 Nitric oxide is known to exert a variety of physiological effects through stimulation 
of soluble guanylate cyclase (sGC) and post-transcriptional S-nitrosation of target 
proteins291.  S-nitrosation of the cysteine-rich zinc binding protein MT is associated with 
structural changes leading to zinc release from the protein222. The physiological 
significance of MT-released zinc in the lung was suggested by the blunted HPV 
observed in the IPL of MT-/- mice, and the attenuated response of MT+/+ mice perfused 
with the zinc chelator TPEN.  In addition, when the known vasodilatory limbs derived 
from NO were removed (through simultaneous inhibition of sGC by ODQ, and calcium 
activated potassium channels by charybdotoxin), the hypoxia-induced changes in 
pulmonary arterial pressure were enhanced, indicating that NO signaling pathways can 
contribute to vasoconstriction in the lung. It was further shown that hypoxia-induced 
increases in labile zinc (by Fluozin-3) were blunted in the presence of the NOS inhibitor 
L-NAME as well as in MT-/- mice, confirming that the hypoxia-induced zinc release is 
both NOS and MT-dependent.  
Stress fibers are dynamic structures consisting of actin filaments bundled by α-
actinin and myosin II motors that span the cell.  This arrangement enables cellular 
contraction through the sliding motion of actin and myosin, resulting in tensile force 
generation.  Interactions between actin and myosin are controlled by the 
phosphorylation state of myosin light chain (MLC).  Phosphorylation of MLC is enabled 
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by activation of MLC kinase or inhibition of MLC phosphatase (MLCP), which induces 
an “active” extended conformation of the protein.   
It was shown that both hypoxia and zinc increased the abundance and alignment 
of actin stress fibers and that these changes were associated with increases in MLC 
phosphorylation, which promoted tension generation and cellular contraction104.  In 
addition, zinc chelation by TPEN attenuated hypoxia-induced changes in actin stress 
fiber formation/stabilization. Pharmacological inhibition of MLCK had no effect on zinc-
mediated changes in MLC phosphorylation or stress fiber formation, indicating that zinc-
induced changes to the actin cytoskeleton appear to be mediated by MLCP inhibition 
instead.   
MLCP consists of a targeting subunit (MYPT1), a catalytic subunit (PP1c), and a 
small subunit of unknown function.  MLCP’s activity may be inhibited by phosphorylation 
of MYPT1 or PP1c.  Western blot analysis of MYPT1 phosphorylation at the Rho-
specific site Thr853 indirectly indicated activation of Rho dependent pathways derived 
from hypoxic exposure or exogenous increases in zinc (Figure 25c).  These 
observations are in agreement with reports indicating the involvement of Rho/ROCK 
activation in response to hypoxia108.  In addition, Rho derived mDia activation may 
contribute to the contractile behavior by promoting filament elongation and stability. 
Further analysis will be required to determine if there is an actual activation of Rho, or 
alternatively another kinase which could be responsible for the increased 
phosphorylation of MYPT1 at Thr853.  Interestingly, zinc chelation during hypoxic 
exposure decreased MLC phosphorylation with no significant decrease in MYPT1 
phosphorylation, indicating that MLCP inhibition was likely mediated by alterations in 
PP1. In addition, the presence of Rho-kinase inhibitor Y-27632 during exogenous zinc 
stimulation clearly decreased MLC and MYPT1 phosphorylation, indicating a possible 
activation of Rho pathways downstream of zinc.  It is important to note though, that 
Y27632 has been associated with inhibition of other proteins including: PKC, cAMP-
dependent protein kinase and myosin light-chain kinase, although with less affinity292.  
Future experiments would need to look closely at the response to dominant negative 
Rho in order to elucidate the effects of zinc on this signaling pathway. 
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 The activity of PKC (a know inhibitor of MLCP) has been reported to be 
influenced by zinc268,293.  In addition, PKCε-null mice were shown to have a blunted 
HPV response254.  Further analysis showed that PKCε, was activated in response to 
hypoxia, as indicated by translocation of the enzyme to the cell membrane; in a NO and 
zinc dependent manner.   Pharmacological inhibition of PKCε, as well as the use of a 
dominant negative mutation, indicated the relevance of this protein in the hypoxia-
induced contractile response of pulmonary endothelial cells.  Finally, it was found that 
CPI-17, a PKC substrate associated with inhibition of the catalytic subunit of MLCP 
(PP1c), was phosphorylated in response to hypoxia and exogenous zinc, and hypoxia-
induced phosphorylation was inhibited by TPEN; further suggesting a contributory role 
in the derived endothelial contraction (Figure 25B). Further analysis will be needed to 
determine if other PKC isoforms may also be contributing to the contractile response. 
 A third alternative for the link between zinc and MLC phosphorylation is based 
on reports indicating a direct inhibitory effect by zinc on Ser/Thr phosphatase PP1 
(Figure 25D) 227.  There is evidence that PP1 contributes to the biomechanical changes 
(i.e., increased stiffness) in pulmonary endothelial cells in response to hypoxia, although 
through the cytoskeletal protein vimentin118,294.  As a fourth alternative, zinc has been 
shown to promote MAP kinase (MAPK) activation by inhibition of its specific 
phosphatase in non-endothelial cells227.  Recent reports have shown that hypoxia-
induced p38 MAP kinase (MAPK) activation, led to MK2 activation and HSP27 
dissociation from actin, promoting polymerization and alteration of pulmonary 
microvascular endothelial cells’ biophysical properties (Figure 25A)118,129.  It should be 
determined if zinc release during the hypoxic stimulus in pulmonary endothelial cells 
may be contributing to MAPK activation and downstream pathways.  
Additional alternatives for downstream targets for zinc include calcium and 
potassium channels. Alveolar hypoxia has been associated with inhibition of voltage-
gated and two-pore domain TWIK-related acid-sensitive potassium (TASK-1) channels, 
resulting in membrane depolarization and calcium entry through L-type channels295.  
High concentrations of ZnCl2 between 100-200µM (10X more than the concentration in 
the used protocols and without the use of an ionophore) have been shown to inhibit 
TASK-1296.  Although this inhibition has been reported in myocytes, recent findings in 
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isolated pulmonary arteries have shown that zinc at these same concentrations did not 
induce increases in tension as expected, presumably because zinc may also inhibit 
downstream L-type voltage-gated calcium channels, resulting in cellular depolarization 
without calcium entry297-298.   
 
Figure 25.  Alternative signaling pathways which may be activated in response to 
increased zinc in the cytosol.  A. Zinc may promote the mytogen activated protein kinase 
(MAPK) signaling though inhibition of its phosphatase, contributing to actin polymerization.  B. 
Zinc may interact with the Rho/ROCK pathway resulting in inhibition of the targeting subunit of 
MLCP and promote actin filament formation through mDia. C. Zinc may result in activation 
protein kinase C epsilon (PKCε) promoting MLCP inhibition by CPI-17. D. Zinc may directly 
inactivate MLCP though interaction with its catalytic core PP1c. 
 
 Further research is required to determine if these or other signaling pathways are 
stimulated during hypoxic vasoconstriction in endothelial cells due to alterations in zinc 
homeostasis, and which of these have a greater physiological relevance.  It is clear 
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though that most of the signaling derived from zinc appears to converge in the inhibition 
of MLCP.   
 
HPV can promote physiologically beneficial results as well as adverse 
pathologies.  In general, the acute response to regional hypoxia effectively promotes 
blood redistribution to maintain proper oxygenation while long-term effects are 
associated with cell remodeling, hypertension and edema.  In a physiological 
environment where the extracellular matrix is not rigid, cellular contraction could enable 
changes in vessel diameter without compromising the barrier integrity.  Since 
maintenance of the barrier function is of great physiological importance, the elucidation 
of signaling pathways promoting vasoconstriction without induced permeability are of 
great relevance in the understanding of pulmonary edema.  
Cytoskeletal and cell attachment alteration in response to zinc have been 
reported sporadically in the literature over the last three decades. A report in the early 
1980s indicated that zinc stabilized focal adhesion complexes in fibroblasts258.  It was 
later shown in the 1990s that long exposure of MDCK cells to high zinc levels increased 
the amount of F-actin, the appearance of plaque-like accumulation of F-actin and 
induced changes in cell shape299.  Evaluation of populations that are zinc deficient 
corroborates the importance of zinc in the development of lung pathologies, such as 
pneumonia207-208.  Studies in rats exposed to two months of a low zinc diet show 
enlarged lungs partially due to edema201. Furthermore, the decreases in the barrier 
integrity of zinc-deficient porcine pulmonary artery endothelial cells further illustrate the 
importance of zinc in the lung and vascular reactivity216.  Zinc supplementation has 
been proven effective in considerably reducing the development of acute lower 
respiratory infections and associated mortality in children, as well as reducing the 
incidence or duration of pneumonia in both age groups207-208.  It would be interesting to 
determine if zinc supplementation could actually contribute to conditions such as 
susceptibility to HAPE and in general the development of pulmonary edema.   
 As zinc is emerging as a novel second messenger, a new role for the metal 
contributing to endothelial cell contraction with physiological relevance in the modulation 
of HPV and pulmonary vascular tone was elucidated.  It was found that NO synthesized 
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in response to hypoxia resulted in posttranscriptional S-nitrosation of MT inducing 
conformational changes and zinc release.  These alterations in zinc homeostasis 
contribute to constriction of small intraacinar arteries of the lung and hypoxia induced 
changes in pulmonary arterial pressure.  This research indicates that the stress fiber 
formation and tension generated in response to hypoxia-induced zinc release, is 
mediated via PKC-dependent inhibition of MLCP, although the possibility that other 
pathways also play a role cannot be eliminated.  This research reveals a novel role for 
the NO/MT/Zn pathway and opens up the field to investigate possible zinc targets 
contributing to the modulation of cellular contractility. 
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LIST OF ABBREVIATIONS 
 
 
ADP  Adenosine diphosphate 
AMC  Adrenomedullary chromaffin  
AMP  Adenosine monophosphate 
APK  AMP-activated protein kinase 
ARDS  Acute respiratory distress syndrome 
BH4  Tetrahydrobiopterin 
BKCa2+  Large conductance Ca
2+-activated potassium channels 
CaM  Calmodulin 
COPD  Chronic obstructive pulmonary disease  
COX-2 Cyclooxygenase-2 
DAG  Diacylglycerol 
DIC  Differential interference contrast 
DQA  Deformation Quantification and Analysis 
ECFP  Enhanced Cyan Fluorescent Protein 
EDFR  Endothelium-derived relaxing factor 
EYFP  Enhanced Yellow Fluorescent Protein 
eNOS  endothelial nitric oxide synthase 
ET-1  Endothelin-1 
FAD  Flavin adenine dinucleotide 
FAK  Focal adhesion kinase 
FMN  Flavin mononucleotide 
FRET  Fluorescence resonance energy transfer 
GFP  Green fluorescent protein 
GSH  Glutathione 
GSSG  Glutathione disulfide 
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HAPE  High altitude pulmonary edema 
HbO2  oxyhemoglobin 
HIF  Hypoxia inducible factor 
HPV  Hypoxic pulmonary vasoconstriction 
iNOS  Inducible nitric oxide synthase 
IPL  Isolated perfused lung 
Kv  Voltage-activated potassium channels 
L-NAME L-Nitro-Arginine Methyl Ester 
LSCM  Laser scanning confocal microscopy 
MAP  Mitongen-activated protein 
MDCK Madin-Darby Canine Kidney Cells 
MK  MAPK-activated protein kinase 
MLC  Myosin light chain 
MLCK  Myosin light chain kinase 
MLCP  Myosin light chain phosphatase 
MLEC  Mouse lung endothelial cells 
MT  Metallothionein 
MTF-1 Metal response element-binding transcription factor 
MYOT1 Targeting subunit of MLCP 
NADPH Nicotinamide adenine dinucleotide phosphate 
nNOS  Neuronal nitric oxide synthase  
N2O3  Dinitrogen trioxide 
NF-ĸB  Nuclear factor-ĸB 
NOX  NADPH oxidase 
NO  Nitric oxide 
NO-   Nitroxyl anion 
NO+  Nitrosonium 
NO2
-  Nitrite 
NOS  Nitric oxide synthase 
OONO- Peroxynitrite 
O2
-  Superoxide 
 88 
PaO2  Partial pressure of oxygen in arterial blood 
PAO2  Partial pressure of oxygen in the alveoli  
PiO2  Partial pressure of oxygen in inspired air 
PAP  Pulmonary arterial pressure 
PEEP  Positive end expiratory pressure 
PKC  Protein kinase C 
PMA  Phorbol myristae acetate 
PPAses Serine/threonine phosphoprotein phosphatases 
PP1  Catalytic subunit of MLCP  
RAEC  Rat aortic endothelial cells 
RBC  Red blood cells 
ROCK  Rho kinase 
ROS  Reactive oxygen species 
RPASMC Rat pulmonary artery smooth muscle cells 
RPMVEC Rat pulmonary microvascular endothelial cells 
sGC  Soluble guanylate cyclase 
SNO  S-nitrosothiols 
SOCE  Store operated Ca2+ entry 
SOD  Superoxide dismutase 
SPAEC Sheep pulmonary artery endothelial cells 
TASK-1 Two-pore acid-sensitive potassium channels 
TPEN  N,N,N′,N′-Tetrakis(2-pyridylmethyl)-ethylenediamine 
TRPC  Transient receptor potential channels 
ZIPK  Zipper-interacting protein kinase 
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